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The SUMO proteases SENP1 and SENP2 are known to reside at the nuclear pore 
complex; however, their functional roles there remain unclear. In this study, SENP1 and 
SENP2 are found to regulate the nuclear pore assembly of components located at the 
central core and cytoplasmic fibrils of the nuclear pore complex. Interestingly, SENP1 
and SENP2 are found to interact with the nuclear basket component Nup153 and regulate 
the SUMOylation status of Nup153. The N- and C-terminal domains of Nup153 are 
found to mediate a bimodal interaction with SENP1/SENP2. Nup153 N-terminal is a site 
of SUMO modification. This modification enhances the interaction between Nup153 and 
SENP1/SENP2. Its C-terminal domain, on the other hand, is found to interact with 
SENP1/SENP2, likely through the bridging interaction mediated by the trafficking 
receptor Importin α. These interactions are likely to contribute to a novel function of 
Nup153 in NPC biogenesis. Depletion of Nup153 or SENP1/SENP2 leads to similar 
defects in NPC assembly of numerous nucleoporins, suggesting Nup153 and 
SENP1/SENP2 are likely to work in the same pathway in mediating NPC biogenesis. 
These findings yielded new insights into the regulatory mechanism of NPC biogenesis in 
which the deSUMOylating activity of SENP1/SENP2 may be coordinated through 
Nup153 at the nuclear basket, to coordinate the assembly of nucleoporins to the sites of 
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The SUMO modification pathway has emerged as an important post-translational 
modification pathway that regulates a variety of cellular events including gene expression, 
maintenance of genomic stability, and cell cycle progression. While recent studies have 
defined various regulatory complexities of this pathway, a mystery remains as to why 
some components of the SUMO modification pathway reside at the nuclear pore complex 
(NPC). A substantial number of studies using yeast as a model organism have 
characterized the relationship between the NPC and the associated SUMO protease Ulp1. 
These studies report functional relevance for this partnership in nucleocytoplasmic 
trafficking, DNA repair, and mRNA surveillance. However, little progress has been made 
in understanding the functional relevance of the NPC-residing SUMO proteases SENP1 
and SENP2 in mammalian cells. In this study, I define a role for SENP1 and SENP2 in 
the biogenesis of NPC. In addition, I have further characterized the biochemical 
relationship between SENP1/SENP2 and components of the NPC and have found
evidence that a partnership between SENP1/SENP2 and the nucleoporin Nup153 is 
required for NPC biogenesis. 1.2 The nuclear pore complex NPCs are enormous protein 
complexes of 40-70MDa with high architectural complexity which serve as the sole 
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gateways of trafficking between the nucleoplasm and cytoplasm. Despite its gigantic size, 
an NPC is assembled by only ~30 different nucleoporins, each in multiple copies, to 
constitute a highly symmetrical organization. When fully assembled, one NPC will have 
an estimated ~450 nucleoporin subunits (Tran and Wente, 2006). Each NPC is statically 
embedded in the nuclear envelope through multiple interactions with inner nuclear 
membrane proteins, nuclear lamina, and chromatin (Daigle et al., 2001; Rabut et al., 
2004). During interphase, new NPCs are constantly assembled and inserted into the 
expanding nuclear envelope (Maeshima et al., 2006; Neumann and Nurse, 2007; Winey 
et al., 1997). However, during mitosis, the nuclear envelope is dispersed into the 
cytoplasm and the NPCs are disassembled into cytoplasmic subcomplexes .  
The architectural structure of the NPC has close ties with its function in 
nucleocytoplasmic trafficking (refer to Figure 1.1 and Figure 1.2). At the nuclear 
envelope, transmembrane nucleoporins (Pom121, Ndc1, gp210) as well as various 
scaffolding (Nup107 and Nup205 complexes) and peripheral nucleoporins (Nup62 
complex) constitute the pore channel spanning the cytoplasm and nucleoplasm. 
Numerous nucleoporins (Nup358, Nup214, Nup88, hCG1, Aladin, Rae1, and Nup98) 
reside on the cytoplasmic side of this pore channel and form cytoplasmic fibrils, which 
mediate the docking of various trafficking receptors. Another group of nucleoporins 
(Nup153, TPR, Nup50, Rae1, and Nup98) localize at the nucleoplasmic face of the pore 
channel, forming a basket-like structure that extends into the nucleoplasm and also 





1.2 Regulation of interphase NPC biogenesis 
 
In higher eukaryotes, both NPCs and the nuclear envelope (NE) are disassembled 
and dispersed throughout the cytoplasm during mitosis (open mitosis). Individual 
subunits or subcomplexes of nucleoporins are then sequentially recruited to chromatin 
and reassembled into functional NPCs in telophase, concurrent with the reformation of 
new nuclear envelope (Antonin et al., 2008; Kutay and Hetzer, 2008). Another pathway 
of NPC assembly occurs during interphase when newly synthesized nucleoporins are 
incorporated into the expanding NE to form NPCs de novo (Doucet and Hetzer, 2010). 
The presence of this distinct pathway is supported by the observation that the number of 
NPCs doubles in higher eukaryotes during S phase (Maul et al., 1972). In addition, NPC-
free islands at nuclear envelope have been observed in early G1 cells which gradually 
disperse in G1/S, concomitant with the increase in NPC density (Maeshima et al., 2006), 
suggesting an active expansion of the NE in early G1 is followed by NPC incorporation 
through S phase. Using in vitro assembled nuclei from Xenopus egg extract, D’Angelo et 
al. showed that new NPCs are assembled from components on both sides of the nuclear 
envelope and do not contain components derived from existing NPCs, reinforcing the 
occurrence of de novo NPC assembly (D’Angelo et al., 2006). Considering the 
complexity of the NPC structure, the NPC assembly process is likely to include layers of 
regulatory steps including the availability of nucleoporins/assembly factors and post-
translational modification of both nucleoporins and regulatory factors (Antonin et al., 
2008). Certainly, phosphorylation has been established as a key modulator of NPC 





1.3 Nonnucleoporin mediators of interphase NPC assembly 
The regulatory mechanisms controlling de novo NPC assembly at interphase have 
been partially uncovered in studies using yeast, as they do not undergo open mitosis and 
have to assemble NPCs de novo into the double bilayer of the nuclear envelope. Multiple 
nonnucleoporin factors have been described in yeast studies to have roles in de novo NPC 
synthesis, including Ran, RanGEF, RanGAP, NTF2 (Ran transport  cofactor), Kap95 
(Importin β homolog), and Kap121 (Importin 5 homolog) (Ryan et al., 2003; Ryan and 
Wente, 2002; Ryan et al., 2007; Lusk et al., 2002). Mutation or depletion of these factors 
can lead to defective incorporation of newly translated nucleoporins into NPCs, resulting 
in accumulation of these nucleoporins in cytoplasmic foci. It is not entirely clear how 
these trafficking-related factors mediate pore assembly but it is thought that RanGTP and 
Kap95 have antagonistic roles, with Kap95 possibly sequestering factor(s) that catalyze 
the fusion of nucleoporin-containing vesicles to NE. RanGTP at the NE would stimulate 
release of factor(s) from Kap95 to allow vesicle fusion (Ryan et al., 2007). Interestingly, 
a role for RanGTP and Importin β in de novo NPC assembly has also been found in the 
Xenopus in vitro NPC assembly system (D’Angelo et al., 2006). Proteins related to the 
ER, including Apq12, reticulons (RTN), and Yop1/DP1, have also revealed to have roles 
in de novo NPC synthesis (Scarcelli et al., 2007; Dawson et al., 2009), possibly through 
their abilities to modulate membrane form and dynamics. In the absence of Rtn1 and 
Yop1, NPC intermediates accumulate at the INM and ONM but failed to fuse to form a 
membrane spanning NPC (Dawson et al., 2009). An unspecified role for the RSC 
chromatin-remodeling complex in NPC assembly has also been described (Titus et al., 
2010). Finally, a recent study in mammalian cells has revealed a role for Cdk1/Cdk2 in 
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regulating the stability and the proper targeting of nucleoporins during interphase NPC 
assembly (Maeshima et al., 2010).  
1.4 Roles of transmembrane nups and scaffolding nups 
in de novo NPC assembly 
 
Numerous studies in yeast have highlighted the importance of transmembrane 
nucleoporins and scaffolding nucleoporins in coordinating de novo NPC biogenesis. (For 
classification of yeast and mammalian nucleoporins, refer to Figure 1.2). Inactivation of 
the yeast transmembrane nups Pom152 and Pom34, as well as the scaffolding 
components Nup59/53 can lead to accumulation of newly synthesized nucleoporins in 
cytoplasmic foci and aberrant dilation of pore diameter (Onischenko et al., 2009). 
Pom152, Pom34, and Nup59/53 can interact as a complex to recruit another 
transmembrane nup Ndc1 and the scaffolding nups Nup170 and Nup157 (Onischenko et 
al., 2009). Disruption of Nup170 and Nup157 also leads to accumulation of nucleoporins 
normally residing at the cytoplasmic fibril and transmembrane region of NPC in 
cytoplasmic foci (Makio et al., 2009; Flemming et al., 2009). In addition, formation of an 
NPC intermediate at the INM that failed to fuse with ONM has also been detected. 
(Makio et al., 2009). Interestingly, these studies show a common trend that those 
cytoplasmic foci accumulating nucleoporins are restricted to the population normally 
residing at the NPC core and the cytoplasmic fibrils. The examined nucleoporins 
normally residing at the nuclear basket (Nup1, Nup2, Nup60, and Mlp1) in these studies 
appear to localize to INM, possibly at NPC intermediates that failed to fuse with the 
ONM (Makio et al., 2009).  
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The functional role of transmembrane nucleoporins and scaffolding nucleoporins 
in mediating de novo NPC assembly has also been characterized in mammalian cells. 
Downregulation of the conserved transmembrane nup NDC1 in mammalian cells can 
severely impair NPC assembly (Mansfeld et al., 2006; Stavru et al., 2006). Interestingly, 
complete knockout of Ndc1 homolog in C. elegans can also severely reduce NPC 
assembly, but rudimentary NPCs can still be assembled, suggesting redundancy among 
the three transmembrane nups Pom121, gp210, and Ndc1 in coordinating NPC assembly 
(Stavru et al., 2006). Indeed, depletion of Pom121 or gp210 can also lead to an NPC 
assembly defect (Antonin et al., 2005; Mansfeld et al., 2006; Funakoshi et al., 2007). In 
addition, codepletion of gp210 and Ndc1 can further enhance the severity of NPC 
assembly defect in mammalian cells (Mansfeld et al., 2006). A recent study reported that 
severe depletion of Pom121 through prolonged RNAi treatment severely inhibits de novo 
NPC assembly, probably through a failure to mediate the fusion of INM and ONM at the 
pore assembly site and subsequent failure to recruit the scaffolding Nup107/160 complex. 
The Nup107/160 complex has been demonstrated to be essential for the de novo NPC 
assembly in both mammalian cells and in the Xenopus in vitro NPC assembly assay 
(D’Angelo et al., 2006; Doucet et al., 2010). A component within the scaffolding 
Nup107/160 complex, Nup133, contains a membrane curvature-sensing domain that 
mediates the recruitment of the Nup107/160 complex to the interphase pore assembly site. 
Interestingly, such a Nup133 recruitment mechanism is not required for post-mitotic NPC 
assembly, highlighting the regulatory divergence between these pore assembly pathways 
(Doucet et al., 2010).  
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1.5 A role of a peripheral nup in NPC assembly 
 
Most of the studies from yeast or mammalian systems have revealed functional 
roles for transmembrane nups and the scaffolding nups located at the core of the NPC in 
mediating the initial steps of de novo NPC assembly. Notably, however, Wu et al. 
reported a role of the peripheral FG nup Nup98 in mediating efficient 
assembly/recruitment of nups residing at the cytoplasmic fibril of NPC. Nup98 knockout 
cells display mislocalization of cytoplasmic fibril nups Nup358, Nup214, Nup88 into 
cytoplasmic annulate lamellae (nucleoporin-containing membranous structure in the 
cytoplasm). In addition, several transport receptors including Importin α, Importin β, and 
Transportin also accumulate in cytoplasmic annulate lamellae. However, the nuclear 
basket nups Nup153 and Nup50 displayed proper localization to the NE (Wu et al., 2001). 
These findings closely resemble the NPC assembly phenotypes reported upon the 
disruption of the scaffolding Nup107 and Nup157 in yeast (Makio et al., 2009; Flemming 
et al., 2009). While it is unclear whether scaffolding nups are efficiently recruited to the 
pore upon the disruption of Nup98, it is likely that the peripheral Nup98 can stabilize the 
NPC assembly process through maintaining interaction networks with multiple nups 
including the scaffolding nups Nup133 and Sec13, the peripheral nup Nup62, and the 
cytoplasmic fibril nup Nup88 and Rae1, thereby stabilizing the gigantic structure of the 
NPC.  
While the role of several core transmembrane/scaffolding/peripheral nups in NPC 
biogenesis has been characterized, the assembly of the sophisticated architecture of the 
NPC is likely to involve additional layers of regulation. As discussed in the following 
sections, the yeast NPC-associated SUMO protease Ulp1 and its mammalian orthologues 
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SENP1 and SENP2 have been found to have intimate interactions with components of the 
nuclear basket as well as the core scaffolding nups, suggesting a possibility of  SUMO-
mediated regulation of nups by Ulp1/SENP1/SENP2. 
1.6 Connection of NPC and SUMO machinery: 
the SUMO conjugation system 
 
The Small Ubiquitin-like Modifier (SUMO) is an 11kD peptide that can be 
covalently attached to a target protein post-translationally and thereby modulate the 
stability, the localization, and the protein-protein interaction properties of the target 
protein. SUMO is first produced as a precursor that requires the SUMO deconjugation 
system (SUMO proteases) to post-translationally process the precursor to expose its C-
terminal diglycine residues for conjugation. There are three SUMO paralogs identified in 
mammalian cells, SUMO1, SUMO2, and SUMO3. All these SUMO paralogs can form 
polySUMO chains in vitro. However, only SUMO2/3 poly-chains have been observed in 
vitro. SUMO is predominantly conjugated to lysine residues within a consensus context 
(ψKxQ/E, where ψ represents hydrophobic residue), through a series of enzymatic 
reactions mediated by the SUMO E1 activating enzyme (Aoa1/Uba2) and the SUMO E2 
conjugating enzyme Ubc9 (Mukhopadhyay and Dasso, 2007). The specificity and 
efficiency of this SUMO conjugation event can be enhanced by a number of localization-
specific SUMO E3 ligases. Members of the SUMO conjugation machinery have been 
reported to have close ties with the nuclear pore complex. It was discovered that the 
cytoplasmic fibril nucleoporin RanBP2/Nup358 possesses SUMO E3 ligase activity 
(Pichler et al., 2002). Together with the SUMO E2 conjugation enzyme Ubc9 and the 
RanGAP1, it is part of a ternary complex. It was later shown that the interaction between 
  
9
SUMO1-RanGAP1 and Nup358 and Ubc9 protects SUMO1-RanGAP1 from being 
targeted by SUMO proteases (Zhu et al., 2009). Notably, this ternary complex does not 
get dissembled during mitosis and has regulatory function in the mitotic microtubule-
kinetochore attachment (Swaminathan et al., 2004; Joseph et al., 2004). Interestingly, 
electron microscopy analysis from Zhang et al. have revealed that Ubc9 localizes to both 
the nuclear basket region as well as the cytoplasmic fibrils of the nuclear pore complex 
(Zhang et al., 2002); however, the binding partner Ubc9 at the basket remains 
unidentified.  
1.7 Connection of NPC and SUMO machinery: 
the deconjugation system 
 
SUMO modification can be highly dynamic as SUMO conjugation is 
counteracted by deconjugation mediated by a class of enzymes called SUMO proteases 
(SENP) (Mukhopadhyay and Dasso, 2007). Numerous SUMO proteases have been 
identified in mammalians and their specific subcellular localization is thought to confer 
specificity in SUMO deconjugation. SENP1 and SENP2 are both reported to be in both 
the cytoplasm and the nucleoplasm, depending on cellular context (Mukhopadhyay and 
Dasso, 2007). However, SENP1 and SENP2 are the only SUMO proteases that also 
localize to the nuclear envelope/nuclear pore. The C-terminal domain of the nuclear 
basket nucleoporin Nup153 has been shown to interact with the N-terminal domain of 
SENP2 (Zhang et al., 2002; Bailey and O’Hare, 2004; Hang and Dasso, 2002). It is 
unclear whether Nup153 is the major docking site of SENP2 at the NPC or if other 
nucleoporins or NPC-associated proteins are involved. In addition, no NPC binding 
partner of SENP1 has been reported.  
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Similar NPC localization of the yeast SUMO protease ortholog Ulp1 has also 
been observed. The binding determinants of Ulp1 at the yeast NPC have been much 
better characterized than its mammalian counterparts SENP1 and SENP2. The 
localization of Ulp1 to NPC is dependent on its interaction with the transport receptors 
Kap121 (mediates mRNA export) and Kap60-Kap95 (mediate classical NLS cargo 
import), and the basket nucleoporins Nup60 (ortholog of mammalian Nup153) and Mlp1-
Mlp2 (ortholog of mammalian TPR) (Panse et al., 2003; Makhnevych et al., 2007; Zhao 
et al., 2004; Lewis et al., 2007). Ulp1 is reported to interact with Kap121 and Kap60-
Kap95 at the proximal and distal regions of its N-terminal domain, respectively. 
Interestingly, these interactions display insensitivity to the presence of RanGTP 
(karyopherins normally release their cargo upon binding to RanGTP) (Panse et al., 2003). 
Deletion of either binding site in Ulp1 only mildly affects its localization, whereas 
deleting both sites leads to mislocalization of the truncated Ulp1 (the C-terminal catalytic 
domain) into the nucleoplasm. While exogenously expressed GFP-Ulp1 is only mildly 
mislocalized in a kap95 mutant, it exhibits more defective localization in a kap121 
mutant. Interestingly, deletion of the Kap60-Kap95 binding site on Ulp1 completely 
mislocalizes its targeting in kap121 mutants, highlighting the cooperative nature of the 
karyopherin binding sites on Ulp1 in mediating its nuclear envelope localization 
(Makhnevych et al., 2007). Although the localization of Ulp1’s mammalian counterpart 
SENP2 has not been reported to be mediated through karyopherin binding, it is notable 
that both Ulp1 and SENP2 rely on their noncatalytic N-terminal domain for proper NPC 
localization (Hang and Dasso, 2002; Zhang et al., 2002). 
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The nuclear envelope localization of Ulp1 is thought to be mediated, in part, 
through components of the NPC, namely Nup60, Mlp1-Mlp2, and the Nup84 complex. 
Mutating Esc1, which coordinates the nuclear basket assembly of Nup60/Mlp1-Mlp2, can 
mislocalize Nup60, Mlp1-Mlp2, together with Ulp1, into perinuclear foci. While the 
Kap121-binding site deletion mutant of Ulp1 can still localize to the nuclear periphery, it 
fails to be recruited to those mislocalized Nup60/Mlp1-Mlp2 foci, underscoring a role for 
Kap121 in mediating Nup60-dependent Ulp1 localization to NPC (Lewis et al., 2007). 
Yet, it is clear that Nup60 and Mlp1-Mlp2 do not provide the sole docking sites for Ulp1 
as it still localizes to the nuclear envelope in nup60Δ cells. In addition, mutations in the 
Nup84 complex (which do not mislocalize Nup60, Mlp1-Mlp2), also result in 
mislocalized Ulp1 (Palancade et al., 2007). Furthermore, overexpressed Ulp1 or its 
Kap121-binding domain can localize to inner nuclear envelope at regions without NPCs 
(Makhnevych et al., 2007; Palancade et al., 2007). These data collectively suggest that 
Ulp1 is likely to use multiple docking sites on NPCs and potentially has other binding 
partners at nuclear envelope.  
1.8 SENP1/SENP2/Ulp1 functions at the nuclear pore complex 
 
The functional roles of SUMO machinery, especially SUMO proteases, at the 
NPC have been characterized in yeast, Drosophila, and mammalian cells. In yeast, 
inactivation of Ulp1 has been reported to share similar phenotypes as the disruption of the 
SUMO activation enzyme, Uba2: defects in nuclear import of proteins containing 
classical nuclear import sequence (cNLS), with nuclear accumulation of Kap60 (yeast 
homolog of Importin α) (Stade et al., 2002). These observations suggest the possibility 
that a cycle of SUMO modification, regulated by Uba2 and Ulp1, on Kap60 or its 
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regulators could mediate the recycling of Kap60. However, the aforementioned cNLS 
import defect in Ulp1 mutated strain can be rescued by expressing maturated SUMO, 
indicating that the defect of cNLS import may be attributed to a lack of SUMO precursor 
processing (Ulp1 is the predominant SUMO protease in yeast that maturates SUMO 
precursor). As such, the mutation of Uba2 or Ulp1 would block cNLS import/ Kap60 
recycling simply through disrupting the SUMOylation of a regulator(s) that mediates 
cNLS import (Stade et al., 2002). It has been speculated that Nup2, which functions in 
recycling of Kap60, could be the target of SUMOylation as Nup2 SUMOylation has been 
reported in a SUMO proteomic study (Hannich et al., 2005; Palancade and Doye, 2008). 
However, the verification of this hypothesis has yet to be reported. Interestingly, multiple 
trafficking factors and nucleoporins have been identified as potential SUMO substrates in 
SUMO proteomic studies (see Table 1.1). While further verification of the SUMOylation 
of these potential targets is required, it is tempting to speculate that certain aspects of 
nucleocytoplasmic trafficking could be regulated through transient cycles of SUMO 
modification on a subset of trafficking factor/nucleoporins.  
A role for a NPC-associated SUMO protease in regulating nucleocytoplasmic 
trafficking has also been reported by Smith et al. Here, downregulation of Drosophila 
Ulp1 leads to the cytoplasmic accumulation of SUMO that is normally detected in the 
nucleus. SUMOylated proteins, including the SUMOylated shuttling protein EPRS, also 
accumulate in the cytoplasm upon the depletion of Ulp1. In this context, Ulp1 is proposed 
to restrict SUMO substrates to the nucleus by deSUMOylating them as they traverse 
through the NPC into the cytoplasm (Smith et al., 2004).  
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NPC association of SUMO proteases has also been reported to sequester their 
deSUMOylation activity away from nucleoplasm. Supporting this notion, overexpression 
of the catalytic domain (which lacks NPC-targeting sequence) of mammalian SENP1 and 
SENP2 and the yeast Ulp1 was found to induce nonspecific deSUMOylation activity and 
result in cell toxicity (Bailey and O’Hare, 2004; Hang and Dasso, 2002; Panse et al., 
2003). Indeed, forced cytoplasmic localization of the Ulp1 catalytic domain through a 
cytoplasmic anchor or NES sequence can rescue the lethal phenotype of Ulp1 deletion, 
indicating that sequestration of Ulp1 deSUMOylating activity from nucleoplasm is a key 
function of Ulp1’s NPC localization (Panse et al., 2003). Similar conclusions have also 
been derived from the observation that mutating the NPC-targeting region of Ulp1 will 
lead to its nucleoplasmic mislocalization and, surprisingly, rescues the lethality and 
hyperSUMOylation phenotypes  generated from Ulp2 (a nucleoplasmic SUMO protease) 
deletion (Li and Hochstrasser, 2003; Lewis et al., 2007). These data suggest that 
compromising the NPC-targeting features of SENP1/SENP2/Ulp1 can mislocalize its 
deSUMOylation activity to nucleoplasm and deregulate the balance SUMO modification 
activity in nucleoplasm.  
Ulp1 has also been revealed to have an unexpected role in mediating the repair of 
DNA double-stranded breaks. Mutation of Ulp1 or its NPC-binding partners 
Nup60/Mlp1/Mlp2 complex or Nup84 complex members leads to the accumulation of 
DNA double-stranded break foci (Soustelle et al., 2004; Loeillet et al., 2005; Palancade et 
al., 2007; Nagai et al., 2008). The accumulation of DNA damage foci in the nucleoporin 
mutants is attributed to the destabilization of Ulp1 upon the disruption of the nuclear 
basket Nup60/Mlp1/Mlp2 complex or the core scaffolding Nup84 complex (Zhao et al., 
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2004; Palancade et al., 2007), which subsequently deregulates the SUMOylation of the 
DNA repair protein Yku70 (Palancade et al., 2007). Collectively, these data indicate the 
NPC binding of Ulp1 is functionally important for its stability and its downstream 
regulatory effect on the DNA repair pathway. 
1.9 Making inroads into a role for SENP1/2 at the NPC 
 
It remains unclear how mammalian SENP1 and SENP2 affect nucleocytoplasmic 
trafficking or other aspects of NPC function. In this study, I first discovered that a 
trafficking regulatory component RanGAP1 at the NPC cytoplasmic fibril is delocalized 
upon SENP1/SENP2 depletion. The disruption caused by the depletion of SENP1/SENP2 
is not limited to RanGAP1 as other components of cytoplasmic fibrils, the core 
scaffolding nups, as well as peripheral nups also display delocalization phenotypes, 
indicative of a larger defect in NPC biogenesis rather than a trafficking specific defect. 
This assembly phenotype converged with a partnership that I have characterized for the 
nuclear basket component Nup153 with SENP1/SENP2, leading to insight into new 
players in the coordination of NPC biogenesis. In contrast with previous model of denovo 
NPC assembly in which the central scaffolding core components (Nup107 complex, 
Nup205 complex, and Nup62 complex) are first recruited to the nuclear pore assembly 
site established by the transmembrane Pom121 (Doucet et al., 2010), data from this study 
suggests that the nuclear basket components are recruited to the nuclear pore assembly 
site prior to the central scaffolding core components. In this model, SUMOylation of the 
newly translated central scaffolding nucleoporin(s) prevent their premature association 
with the transmembrane nucleoporin Pom121 at the cytoplasm. Such premature 
association with Pom121 may interference with Pom121 ability to mediate NE fusion. 
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The nuclear basket component Nup153 will be recruited first to the Pom121 NE fusion 
site, bringing SENP1/SENP2 to the vicinity of the nuclear pore assembly site to mediate 
the deSUMOylation of central scaffolding components, allowing coordinated association 
of these components with Pom121. 
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Figure 1.1. Classification of mammalian nucleoporins. The nuclear pore complex has 
a basic structure of a central pore channel that spans the nuclear envelope, with 
cytoplasmic fibrils and nuclear basket-like structures protruding from the central channel 
facing the cytoplasm and the nucleoplasm respectively.  The various nucleoporins and 
their classification into transmembrane nup, scaffolding nup, or peripheral nup are 
highlighted in this diagram 
Adapted from 






Figure 1.2. Comparison of the mammalian and yeast nucleoporins.  The 
localization of the mammalian (left) and yeast (right) transmembrane, scaffolding, and 
peripheral nucleoporins and their homologous/orthologous counterparts are 
symmeterically arranged in this NPC diagram. The nucleoporins boxed in purple color 
at the central core are conserved subcomplexes of the scaffolding nups (Nup107-160 
complex in mammal and Nup84 in yeast). The mammalian Nup153 at the nuclear 
basket has a functional ortholog Nup60 in yeast, both form a complex with the 
orthologous TPR (mammal) and Mlp1/Mlp2 (yeast) respectively (in blue boxes). 
Components of the SUMO machinery are highlighted in red boxes with red lines 
connecting to their binding determinants at the pore.  The binding determinant(s) of 
the SUMO protease SENP1 and Ubc9 (in green boxes) at the nuclear basket have not 
been determined. 
Adapted from     





Listed here are potential SUMO targets of that have been identified through various 
SUMO proteomic studies.  Non e of the targets have been experimentally verified in 
these studies to have SUMO modification. 
Table 1.1. Potential SUMO targets of trafficking factors and nucleoporins 
CHAPTER 2 
 
THE SUMO PROTEASES SENP1 AND SENP2 HAVE A NOVEL                 
FUNCTION IN NPC BIOGENESIS 
2.1 Abstract 
 
The SUMO proteases SENP1 and SENP2 are known to localize to the nuclear 
pore complex (NPC). However, their functional roles at this site are poorly defined. In 
this study, SENP1 and SENP2 are shown to have a redundant role that influences NPC 
biogenesis. Depletion of SENP1/SENP2 was found to result in a nuclear pore assembly 
defect characterized by mislocalization of nucleoporins normally found at the 
cytoplasmic fibrils and the central core of the NPC. Interestingly, no assembly defect was 
observed for components of the nuclear basket. The nuclear basket component Nup153 
interacts with both SENP1 and SENP2. Here, we show that this is due to a bimodal 
interaction that requires discrete regions in both the N- and C-terminal domains of 
Nup153. In addition, depletion of Nup153 results in a similar nuclear pore assembly 
defect, suggesting that SENP1/SENP2 and Nup153 work in the same pathway in 






The nuclear pore complex (NPC) is a structure embedded in the nuclear envelope 
that regulates nucleocytoplasmic trafficking of macromolecules. Each NPC is assembled  
by numerous nucleoporins (Nups) with specialized architectural and trafficking roles. 
These Nups can be generally categorized as the transmembrane Nups, scaffolding Nups, 
and peripheral Nups, and are assembled into a membrane-spanning central channel with 
cytoplasmic fibrils and a basket-like structure protruding into the cytoplasm and 
nucleoplasm respectively (Tran and Wente, 2006). In higher eukaryotes, the NPC is 
disassembled in concert with dispersal of the nuclear envelope at mitosis. Both NPCs and 
the nuclear envelope reform in late anaphase telophase. The assembly of NPCs post-
mitosis has been well studied in terms of the sequential recruitment of nucleoporins to the 
nascent nuclear envelope and the requirement for certain nups in mediating NPC 
assembly (Antonin et al., 2008). In interphase, new NPCs are continuously assembled 
into the expanding nuclear envelope; however, the process of interphase NPC assembly 
remains poorly understood. Recent studies in mammalian cells have highlighted several 
key regulatory players in pore assembly, including the transmembrane nups Pom121 and 
Ndc1, the scaffolding Nup133 , the peripheral Nup98, as well as Cdk1/Cdk2 (Antonin et 
al., 2005; Mansfeld et al., 2006; Stavru et al., 2006; Funakoshi et al., 2007; D’Angelo et 
al., 2006; Doucet et al., 2010; Wu et al., 2001; Maeshima et al., 2010). Similar 
requirements of transmembrane/scaffolding/peripheral nups in regulating NPC biogenesis 
have also been observed in yeast, in which NPCs are continuously assemble into an intact 
NE as reviewed by (Doucet and Hetzer, 2010).   
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The NPC has been reported as a localization site for several enzymes of the 
SUMO modification pathway. The mammalian SUMO E2 conjugating enzyme Ubc9 is 
localized at both the cytoplasmic fibrils and the nuclear basket structures of the NPC 
(Zhang et al., 2002). At cytoplasmic fibrils, Ubc9 forms a tight complex with the 
trafficking factor RanGAP1 and the nucleoporin Nup358/RanBP2 (Matunis et al., 1996; 
Mahajan et al., 1997; Matunis et al., 1998; Saitoh et al., 1997), which itself is reported to 
have SUMO E3 ligase activity (Pichler et al., 2002). On the nucleoplasmic side of the 
NPC, the nuclear basket is a localization site for the SUMO proteases SENP1 and SENP2 
(Palancade and Doye, 2008). SENP2 is known to interact with the nuclear basket 
component Nup153 (Hang and Dasso, 2002; Zhang et al., 2002), while the pore-binding 
partner of SENP1 has yet to be identified. Such NPC association for SUMO proteases 
appears to be conserved as similar localization has been reported for the yeast and 
Drosophila SUMO proteases, termed Ulp1 (Li and Hochstrasser, 2003; Smith et al., 
2004). In yeast, Ulp1 NPC localization is mediated by the nuclear basket Nup60-Mlp1/2 
complex, the core scaffolding Nup84 complex and the transport receptors Kap121, 
Kap60/Kap95 (Panse et al., 2003; Zhao et al., 2004; Palancade et al., 2007). 
Emerging evidence indicates that NPC-associated SUMO proteases are involved 
in mediating various aspects of NPC function. For example, disruption of the yeast Ulp1 
results in a recycling defect of the transport receptor Kap60 and defective import of cNLS 
cargo (Stade et al., 2002). In addition, disruption of the Drosophila Ulp1 results in 
aberrant cytoplasmic accumulation of SUMO, suggestive of a role in restricting SUMO 
modification to the nucleus (Smith et al., 2004). Other noncanonical NPC functions, such 
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as DNA repair and DNA replication, have been found to depend on the NPC connection 
of yeast Ulp1 (Palancade et al., 2007; Loeillet et al., 2005).  
In this study, we have characterized a role for the mammalian NPC-associated 
SENP1 and SENP2 in mediating NPC biogenesis. This function of SENP1/SENP2 is 
likely to be coordinated through Nup153. First, Nup153 is found to be a binding partner 
for SENP1, as previously reported for SENP2 (Zhang et al., 2002). Moreover, 
downregulation of SENP1/SENP2 or Nup153 leads to similar disruption of NPC 




2.3.1 Codepletion of SENP1 and SENP2 perturbs cellular  
 
distribution of RanGAP1 
 
Evidence from yeast and Drosophila studies has suggested a role of pore-
associated SUMO proteases in regulating aspects of nucleocytoplasmic trafficking (Stade 
et al., 2002; Smith et al., 2004). Using a siRNA knockdown approach, we sought to 
determine if nucleocytoplasmic trafficking machinery is perturbed when SENP1 and 
SENP2 are downregulated. As shown in Figure 2.1A, siRNA oligos against SENP1 or 
SENP2 in Hela cells resulted in significant depletion of SENP1 or SENP2 48 hours post-
transfection. An independent set of SENP1/SENP2 oligos was also tested, with similar 
knockdown efficiency (Figure 2.1A). Indirect immunofluorescence analysis of cells 
transfected with both sets of SENP1/SENP2 siRNA oligos revealed no gross perturbation 
in the distribution of the trafficking factors Exportin1, Transportin, RCC1, CAS, Importin 
α, and Importin β (Figure 2.1B-D). However, depletion of SENP2 resulted in 
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accumulation of the trafficking factor RanGAPl in cytoplasmic foci, whereas the nuclear 
basket component TPR was unperturbed (Figure 2.2). Interestingly, such mislocalization 
of RanGAP1 became more severe when SENP1 and SENP2 were codepleted. In contrast, 
downregulation of SENP1 alone did not result in a detectable mislocalization of 
RanGAP1 (Figure 2.2). These observations suggest that SENP1 may have an auxiliary 
role, along with SENP2, in the regulation of RanGAP1 distribution.  
RanGAP1 has been previously reported as the predominant SUMO1 substrate in 
cells and its SUMO1 modification allows it to form a tight complex with Ubc9 and 
RanBP2 at cytoplasmic fibrils of the NPC (Matunis et al., 1996; Mahajan et al., 1997; 
Saitoh et al., 1997; Matunis et al., 1998). We therefore tested whether RanGAP1 is 
delocalized in cytoplasm in a SUMO1-modified form upon SENP1/SENP2 depletion. As 
shown in Figure 2.3, cytoplasmic foci accumulation of SUMO1 is detected upon SENP2 
depletion or, more so, with SENP1/SENP2 codepletion. Consistent with the idea that 
SUMO1-modified RanGAP1 is delocalized in the cytoplasm, we were unable to detect 
any delocalization of SUMO2/3 upon SENP1/SENP2 depletion. In addition, western 
analysis shows no change on the SUMO status of RanGAP1 upon SENP1/SENP2 
depletion (not shown). Depletion of SENP1/SENP2 using an independent set of siRNA 
oligos similarly resulted in delocalization of endogenous SUMO1 but not SUMO2/3 
(Figure 2.3). These observations were independently verified using Hela cell lines that 






2.3.2 Members of the RanGAP1-Ubc9-RanBP2 complex, Nup62, and  
Nup133 are delocalized upon SENP1/SENP2 codepletion 
 
Since SUMO1-modified RanGAP1 is known to form a tight complex with Ubc9 
and RanBP2 at the cytoplasmic fibril of NPC, we next examined whether Ubc9 and 
RanBP2 are similarly delocalized upon SENP1/SENP2 depletion. As shown in Figure 2.5, 
both Ubc9 and RanBP2 were detected in cytoplasmic foci upon the depletion of SENP2 
or codepletion of SENP1 and SENP2. As revealed by the 414 antibody (which recognizes 
RanBP2/Nup358, Nup214, Nup153, and Nup62) as well as the RanGAP1 antibody, the 
mislocalization phenotypes of these proteins occur at high penetrance (Figure 2.6 
left/central panels). Similar to the RanGAP1 delocalization phenotype, the Ubc9 and 
RanBP2 delocalization phenotypes are less severe with single depletion of SENP2 
(Figure 2.5, Figure 2.6). To determine if these defects are specific to components of the 
cytoplasmic fibrils of the NPC, we next examined whether nucleoporins situated at other 
architectural elements of the NPC are similarly delocalized. Nup62, a symmetrical core 
peripheral nucleoporin (Figure 2.6 right panel), as well as Nup133, a member of the 
scaffolding Nup107 complex (Figure 2.14A), are found to colocalize as cytoplasmic foci 
upon SENP1/SENP2 codepletion. Interestingly, the transmembrane Pom121 (Figure 2.7) 
and the nuclear basket nucleoporins Nup153 (Figure 2.7) and TPR (Figure 2.2) exhibit 
normal localization upon SENP1/SENP2 codepletion, implicating regulatory specificity 







2.3.3 The nuclear basket Nup153 is a novel binding partner and 
 target of SENP1 
 
Nup153 has been reported to interact with SENP2, possibly serving as a SENP2 
docking site at the nuclear basket (Zhang et al., 2002). However, the nuclear pore binding 
partner of SENP1 has not been reported. We therefore first tested whether SENP1 can 
interact with Nup153. To this end, GFP or GFP-SENP1 fusion protein were individually 
expressed in Hela cells and then trapped on an affinity matrix for binding analysis. As 
shown in Figure 2.8A (lane 7), Nup153 is co-recovered with GFP-SENP1. The lack of 
detectable Nup50 or Nup62 in association with GFP-SENP1 underscores the specificity 
(Figure 2.8A). The control GFP protein alone does not bind to any of the tested 
nucleoporins (Figure 2.8A, lane 6).  
Bailey et al. previously showed that a population of SENP1 can be detected in the 
cytoplasm in addition to its predominant nuclear and nuclear rim localization. SENP1 
seemed to have exclusive nuclear localization when it is catalytically inactivated, 
suggesting that the enzymatic activity of SENP1 could play a role in mediating its 
localization (Bailey and O’Hare, 2004). We therefore examined whether the catalytic 
activity of SENP1 influences its interaction with Nup153. As shown in Figure 2.8A, both 
wildtype and the catalytic dead (CD) GFP-SENP1 fusion proteins can interact with 
endogenous Nup153. However, expression of the catalytic dead SENP1 results in a 
modified form of Nup153 that interacts significantly more robustly.  
A previous study using catalytic dead SENP1 resulted in enrichment of a SUMO 
target that it regulates (Witty et al., 2010). We therefore considered whether the modified 
form of Nup153 is SUMOylated Nup153. To verify if Nup153 is indeed a SUMO target 
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regulated by SENP1 and SENP2, these enzymes were individually depleted or codepleted 
by siRNA in a Hela cell line that stably expresses T7-tagged SUMO3. Nup153 was then 
immunoprecipitated from cell lysates and subjected to western analysis using anti-T7 
antibody. As shown in Figure 2.8B, downregulation of SENP1 or SENP2 reveals some 
T7-SUMO3 modification of Nup153. Codepletion of SENP1 and SENP2 synergistically 
enhances detection of T7-SUMO-modified Nup153, demonstrating that Nup153 is a 
SUMO target coregulated by SENP1 and SENP2. Similar observation was made when 
overexpression of catalytic dead SENP2 resulted in the SUMO modification of Nup153 
(Figure 2.8C). In this assay, the catalytic dead SENP2 was coexpressed with T7-tagged 
SUMO1, SUMO2, or SUMO3. Nup153 was then immunoprecipitated from cell lysates 
and subjected to western analysis using T7 antibody. As shown in Figure 2.8C, Nup153 
is detected modified by SUMO2 and SUMO3, highlighting the role of SENP2 towards 
the SUMO regulation of Nup153.  
2.3.4 Nup153 has dual binding platform for SENP1 
 
To map which domains of Nup153 interact with SENP1, we coexpressed GFP-
SENP1 fusion protein together with Flag-tagged fusion proteins of the three domains of 
Nup153. GFP alone was used as a binding control. Western analysis of GFP proteins 
recovered from cell lysates revealed that SENP1 bind to both the N- and C-terminal 
domain of Nup153 although binding to the N-terminal domain appeared considerably 
weaker than  interaction with the C-terminal domain (Figure 2.9A). Interestingly, in this 
binding assay, we also detected a similar interaction between SENP2 and the N-terminal 
domain of Nup153, along with more robust binding to the C-terminal domain (Figure 
2.9A). SENP2 is reported to interact with the Nup153 C-terminal domain, but not its N- 
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or zinc finger domain (Zhang et al., 2002). A difference in detection sensitivity could 
explain why SENP2 was not previously found interact with Nup153’s N-terminal domain. 
Consistently, however, we do not detect binding between either SENP1or SENP2 and the 
zinc finger domain of Nup153 (Figure 2.9B). Collectively, these findings indicate that 
Nup153 has a dual binding platform for both SENP1 and SENP2.   
2.3.5 Characterization of SENP1 binding to Nup153 C-terminal domain 
 
The most prominent feature of the C-terminal domain of Nup153 is its FG rich 
nature, which is a property shared by several nups and facilitates interactions with 
transport receptors. Yet within this region, there are distinctions: the proximal end of the 
C-terminal domain contains FG linkers that are rich in acidic residues when compared 
with the FG linkers at the distal end (see Figure 2.10B). In addition, a specific binding 
site for Importin α has been mapped to the terminal residues (Figure 2.10B underlined) 
(Moroianu et al., 1997). To test the contribution of these features, we engineered various 
constructs, encompassing the full-length C-terminal domain (875-1475), or its proximal 
(875-1262) and distal (1263-1475) regions. The Importin α binding site was deleted to 
create CΔ (875-1457) and C-distalΔ (1263-1457). This panel of GFP fusion proteins was 
expressed in Hela cells and then recovered and analyzed for SENP1 binding. As shown in 
Figure 2.10A, the C-terminal domain and its proximal and distal ends bind to endogenous 
SENP1 and SENP2; however, the interaction of SENP1/SENP2 with the distal region is 
consistently more robust. Truncation of the specific Importin α binding site from the C-
terminal domain or the C-distal region resulted in significant loss of SENP1/SENP2 
binding (Figure 2.10B). These observations collectively suggest that Nup153 interaction 
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with SENP1/SENP2 is bridged by Importin α binding predominantly to a terminal site in 
the C-terminal domain. 
2.3.6 SUMOylation of Nup153’s N-terminal domain modulates  
its interaction with SENP1 
 
As shown in Figure 2.8A, catalytic dead SENP1 or SENP2 is found to interact 
robust with SUMOylated Nup153, suggesting that cycles of SUMOylation on Nup153 
could be a recruiting signal for SENP1/SENP2. To test this possibility, we first mapped 
which domain of Nup153 contains the SUMOylation site. Coexpression of catalytic dead 
SENP1 with Nup153’s N-terminal domain leads to an accumulation of a modified form 
of N-terminal domain (Figure 2.11A). In contrast, coexpression with wildtype SENP1 did 
not result in N-terminal domain modification. Under these assay conditions, the zinc 
finger and C-terminal domain displayed no sign of being modified (Figure 2.11A). Based 
on the finding that catalytic dead SENP2 leads to the SUMOylation of Nup153 (Figure 
2.8C), we conclude that the N-terminal domain of Nup153 is the SUMOylation site.  
To next determine if SUMOylation of the Nup153 N-terminal domain enhances 
interaction with SENP1, we affinity-captured GFP-SENP1 and examined what species of 
Flag-tagged N-terminal domain was co-recovered. As shown in Figure 2.11B, both GFP-
SENP1 wildtype and catalytic dead fusion proteins can interact with the unmodified Flag-
tagged N-terminal domain of Nup153. However, the catalytic dead GFP-SENP1 fusion 
protein consistently forms a robust association with a modified species of the Nup153 N-
terminal domain (Figure 2.11B). A similar observation is seen with respect to the 
interaction between SENP2 and the Nup153 N-terminal domain. No enhanced interaction 
is detected in the case of Nup153’s C-terminal domain interaction with SENP1 or SENP2 
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(Figure 2.11B). These observations suggest that the N-terminal domain is SUMOylated 
and this modification enhances SENP1/SENP2 association. Collectively, both the ability 
to bind Importin α and be a target of SUMO modification may allow Nup153 to 
coordinate a bimodal interaction with SENP1 and SENP2.      
2.3.7 Nup153 is a specific SUMO target regulated by SENP1 and SENP2 
 
To further examine the specificity of SENP1/SENP2-SUMO regulation towards 
nucleoporins and NPC-associated proteins, we dominantly interfered with the 
deSUMOylating activity of endogenous SENP1 or SENP2 by overexpressing catalytic 
dead versions of SENP1 and tracked the SUMOylation status of a variety of 
nucleoporins/associated proteins. As shown in Figure 2.12A, Nup153 is robustly 
SUMOylated when catalytic dead SENP1, but not wildtype SENP1, is overexpressed. 
However, the nucleoporins TPR, Nup50, Nup358, Nup98, Nup62, and NPC-associated 
proteins LaminA, LaminB2, and Importin β are not detectably SUMOylated. Similar 
results are found in cells overexpressing catalytic dead SENP2 (not shown). 
Overexpression of the catalytic dead version of the nucleoli-specific SUMO protease 
SENP3, however, did not result in Nup153 SUMOylation (Figure 2.12B). Together, these 
observations suggest Nup153 is a specific NPC SUMO target regulated by the pore-
associated SENP1 and SENP2.  
2.3.8 Nup153 regulates NPC biogenesis 
 
Since SENP1 and SENP2 bind to Nup153, it is possible that Nup153 coordinates 
the SENP1/SENP2 regulatory role in NPC biogenesis by recruiting them to the nuclear 
pore. We therefore probed for a role of Nup153 in NPC biogenesis. Nup153 has been 
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previously described to mediate the post-mitotic assembly of the nuclear basket, with 
moderate depletion of Nup153 resulting in delocalization of the nuclear basket 
components Nup50 and TPR exclusively in cells undergoing cytokinesis (Mackay et al., 
2010). In addition, near-complete depletion of Nup153 has been reported to prevent all 
recruitment of TPR and Nup50 to the nuclear basket (Hase and Cordes, 2003). We have 
now uncovered a distinct NPC assembly defect upon moderate depletion of Nup153. As 
shown in Figure 2.13, downregulation of Nup153 using siRNA resulted in accumulation 
of RanGAP1 (Figure 2.13A), Ubc9, Nup358/RanBP2, Nup62 (Figure 2.13B), and 
Nup133 (Figure 2.14A) in cytoplasmic foci in cells. In contrast, the transmembrane 
nucleoporin Pom121 (Figure 2.14B) and the nuclear basket nucleoporin TPR (Figure 
2.13A) do not exhibit signs of delocalization. Moderate downregulation of Nup153 using 
an independent siRNA oligo also yielded similar phenotypes (Figure 2.15). In contrast, 
downregulation of other nuclear basket nucleoporins Nup50 (Figure 2.13) or TPR (not 
shown) did not result in any localization defect of the aforementioned nucleoporins or 
associated proteins. The cytoplasmic foci phenotypes of select nucleoporins and 
associated proteins upon moderate downregulation of Nup153 are highly similar, albeit 
with greater phenotypic severity, to those observed upon the codepletion of SENP1 and 
SENP2. Coupled with the observation that SENP1/SENP2 interacts with Nup153 and 
regulates its SUMOylation status, it is possible that SENP1, SENP2, and Nup153 work in 










2.4.1 Interphase NPC biogenesis 
 
The major distinguishing feature of interphase NPC biogenesis is that the NPC 
must assemble into a preexisting double lipid bilayer. Whereas Pom121 is dispensable for 
the earlier, post-mitotic route of NPC assembly, this transmembrane nucleoporin is 
implicated in facilitating INM/ONM fusion followed by the recruitment of the Nup107 
scaffolding complex during interphase NPC assembly (Doucet et al., 2010). The 
regulation of the various steps of interphase NPC biogenesis are not well characterized, 
but import of the transmembrane protein Pom121 to the INM, as well as the curvature 
sensing domain of Nup133 within the Nup107 complex are crucial for initiating 
establishment of nascent pores (Doucet et al., 2010; Doucet and Hetzer, 2010). A role of 
Cdk1/Cdk2 in the interphase NPC biogenesis has also been established but it is unclear 
how Cdk1/Cdk2 is exerting its influence (Maeshima et al., 2010). 
2.4.2 Novel role of Nup153, SENP1, and SENP2 in NPC biogenesis 
 
In this study, we have uncovered the nuclear basket nucleoporin Nup153 and its 
binding partners SENP1 and SENP2 as additional players in the interphase NPC 
biogenesis pathway. Downregulation of SENP1/SENP2 or Nup153 leads to accumulation 
of Nup358, Ubc9, RanGAP1, Nup133, and Nup62 in cytoplasmic foci, while the 
localization of the Pom121 and the nuclear basket nucleoporins Nup153 and TPR remain 
normal. This suggests that in the absence of SENP1/SENP2, Pom121 can still be 
efficiently recruited to the INM/ONM but lack of deSUMOylation activity from Nup153-
associated SENP1/SENP2 may block subsequent recruitment of Nup133, Nup62, and the 
Nup358-Ubc9-RanGAP1complex. A possible model is that some nucleoporins and/or 
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associated proteins at this stage are SUMO-modified, which could block their premature 
recruitment to the nascent interphase nuclear pore structure, possibly through interference 
of protein-protein interactions. Spatially-restricted SENP1/SENP2-mediated 
deSUMOylation may in turn allow these nucleoporins/associated proteins to establish 
interaction with the nascent pore structures. Such SUMO-mediated regulatory features of 
nucleoporins or associated proteins may coordinate precise spatiotemporal regulation of 
nuclear pore assembly.  
2.4.3 Cytoplasmic foci of nucleoporins/associated proteins upon 
SENP1/SENP2 or Nup153 depletion 
 
The nature of the cytoplasmic structures that host the delocalized population of 
nups/associated proteins upon SENP/Nup153 depletion remains unclear. Our analysis 
revealed that some of these proteins colocalize as cytoplasmic aggregates. Upon 
SENP/Nup153 depletion, the scaffolding nup Nup133 colocalized with the peripheral nup 
Nup62 in cytoplasmic foci. While no direct interaction between Nup133 and Nup62 has 
been reported, it is possible that they may indirectly associate through a network of 
protein-protein interactions among the nucleoporins. Since it is unclear whether certain 
nucleoporins form subcomplexes in the cytoplasm before being incorporated to the NPC 
assembly site, it is tantalizing to postulate that the Nup133/Nup62 cytoplasmic foci may 
reflect an intermediate subcomplex that failed to be incorporated into NPC in the absence 
of SENP/Nup153. Alternatively, these cytoplasmic foci of nucleoporins could be 
nucleoporin-enriched membrane structures called annulate lamellae. We did not detect 
Pom121 in cytoplasmic foci upon the depletion of SENP/Nup153, but the other two 
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transmembrane nups GP210 and Ndc1 may be present and sufficient to induce the pore-
like structures found in annulate lamellae.  
2.4.4 Nup153 mediates bimodal interactions with SENP1 and SENP2 
 
We have found that Nup153 provides a dual binding platform for SENP1 and 
SENP2. The C-terminal domain of Nup153 is likely to coordinate an Importin α-
mediated interaction with SENP1/SENP2 while SUMOylation of Nup153’s N-terminal 
domain serves as a second SENP1/SENP2 recruitment signal. Such bimodal interactions 
between Nup153 and SENP1/SENP2 may allow regulated targeting of SENP1/SENP2 
activity towards various proteins that bind to Nup153. The targeting of SENP1/SENP2 
activity through Nup153’s N- and/or C-terminal domain could be an important event in 
coordinating regulated deSUMOylation of SUMOylated nucleoporins or associated 
proteins present during assembly of intermediate structures of the interphase nuclear pore. 
Through the current and previous studies, Nup153, Nup358, RanGAP1, and Lamin A are 
the only nucleoporin/associated protein confirmed to be SUMO modified (Pichler et al., 
2002; Matunis et al., 1996; Zhang and Sarge, 2008); SUMO proteomic studies have 
identified other relevant targets such as Nup205, Nup214, TPR, and Importin β (Matafora 
et al., 2009). While the SUMOylation of these targets has yet to be experimentally 
verified, it is possible that transient SUMOylation of certain nucleoporin/associated 
proteins and their subsequent deSUMOylation mediated through the Nup153-





2.4.5 Subset of nucleoporins contribute to NPC assembly 
 
The Nup153 depletion phenotype draws striking similarity to a previously 
characterized feature of Nup98 knockout cells which displayed cytoplasmic accumulation 
of numerous nucleoporins including the peripheral Nup62 and members of cytoplasmic 
fibrils, RanBP2, Nup214, and Nup88 (Wu et al., 2001). However, members of the nuclear 
basket Nup153, Nup50, and a member of the scaffolding Nup107 complex, Nup96, did 
not show delocalization in Nup98 knockout cells (Wu et al., 2001). These observations 
suggest that a subset of nucleoporins, such as Nup153 and Nup98, may have fundamental 
roles in coordinating NPC biogenesis. However, it is unlikely that Nup98 shares the 
specific mechanistic role of coordinating SENP1/SENP2 activity since Nup98 does not 
seem to bind to SENP1 (not shown) and SUMO modification of Nup98 was not detected 
in our experiments (not shown). The reported interaction between Nup98 and both 
Nup133 and Nup88 (Belgareh et al., 2001; Griffis et al., 2003) suggests that Nup98 could 
be important in stabilizing the Nup107 complex and members of the cytoplasmic fibrils.  
2.4.6 Nup153 coordinates both interphase and mitotic NPC assembly 
 
In this study, a role for Nup153 in regulating NPC assembly has been 
characterized in relation to its partnership with SENP1/SENP2. Interestingly, Nup153 has 
recently been found to lead to a distinct phenotype in post-mitotic cells, where 
downregulation of Nup153 results in accumulation of the nuclear basket components 
Nup50 and TPR in cytoplasmic foci. This nuclear basket assembly defect has been 
associated with the activation of an Aurora B-mediated abscission checkpoint and results 
in abscission delay (Mackay et al., 2010). Here, we consistently observed that 
downregulation of Nup153 leads to Nup50 and TPR foci exclusively in cells undergoing 
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cytokinesis (not shown). A more thorough survey found, however, that upon Nup153 
depletion, assembly defect of Nup62, RanBP2, RanGAP1, Ubc9, and Nup133 are 
observed in a large population of cells. Importantly, these latter NPC assembly defects 
are not restricted to cells undergoing cytokinesis and, indeed, are more prevalent in G1/S 
cells. The hallmark phenotypes of cytoplasmic mislocalization of nucleoporins/associated 
proteins upon SENP1/SENP2 or Nup153 depletion share striking similarity with the 
interphase NPC assembly defects reported when Cdk1/Cdk2 or scaffolding nups are 
disrupted (Maeshima et al., 2010; Makio et al., 2009).  
The nuclear basket Nup50 and TPR appear to have no role in coordinating the 
pore assembly of Nup62, RanBP2, RanGAP1, and Ubc9 as depletion of TPR or Nup50 
did not lead to similar phenotypes. In addition, although the levels are reduced at the 
nuclear rim, Nup50 and TPR are not detected to be mislocalized to cytoplasmic foci in 
G1/S cells upon Nup153 depletion. Furthermore, a role of Nup153 in mediating the post-
mitotic nuclear basket assembly of Nup50 and TPR appears to be independent of its 
partnership with SENP1/SENP2 as no cytoplasmic foci accumulation of Nup50 or TPR is 
detected upon the depletion of SENP1/SENP2. Collectively, these observations suggest 
that during post-mitotic assembly, Nup153 is critical for rapid assembly of basket 
assembly. As cells transition from telophase into late cytokinesis/G1, Nup153 coordinates 
the proper incorporation of Nup62, Nup133, and components of cytoplasmic fibrils into 
NPCs. The similar phenotypic profiles of SENP1/SENP2 knockdown, as well as their 
association with Nup153, suggest that these proteins converge in a regulatory mechanism 




2.5 Materials and Methods 
 
2.5.1 siRNA depletion of SENP1, SENP2, Nup153, and Nup50 
 
Previously validated siRNA oligos against SENP1 (Li et al., 2008; Yun et al., 
2008), SENP2 (Yun et al., 2008; Zhu et al., 2009), Nup153 and Nup50 (Mackay et al., 
2009)  were transfected into Hela cells (in 10 μM final concentration) for 48 hr using 
Lipofectamine RNAi MAX as previously described in Mackay et al.   
2.5.2 Indirect immunofluorescence analysis 
 
Hela cells post RNAi treatment were rinsed with 1xPBS followed by one of the 
following fixation methods: for RanGAP1, Ubc9, SUMO1, and SUMO2/3 antibody 
staining, cells were fixed for 10 min 3% PFA followed by 2min MeOH at -20°C; for 
antibody against TPR, Nup153, Nup358, or Nup62 antibody staining, cells were fixed 4 
min with MeOH at -20°C. Following fixation, cells were rinsed and blocked with 3% 
FBS in 1xPBS, 0.02% Tx100 for 30 min. Subsequent antibody treatments were 
performed as described in Mackay et al. 
2.5.3 GFP affinity trap and co-recovery analysis 
 
Hela cells were lysed with lysis buffer (1xPBS, 0.25% Tx100, 60mM β-
Glycerolphosphate, 10mM Sodium Orthovanadate, 2x COMPLETE protease inhibitor, 
40mM N-Ethylmaleimide). Following brief sonication and centrifugation, 200-500 μg of 
cell lysates were incubated with 10 μL of GFP-Trap agarose beads (Chromotek) for at 
least 30 min. Beads were later washed 3 times with lysis buffer (without the protease 
inhibitor/ N-Ethylmaleimide). Proteins were eluted with SDS loading buffer and 
subjected to western analysis. 
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2.5.4 Nup153 immunoprecipitation and T7-SUMO3  
modification analysis 
 
Hela cells stably expression T7-tagged SUMO3 were treated with SENP1/SENP2 
siRNA oligos and lysates were generated as described above. Cell lysates were later 
incubated with Nup153 antibody (SA1) (Bodoor et al., 1999) preimmobilized on protein-
G beads for 4 hr at 4°C. Proteins were eluted with SDS loading buffer and subjected to 
western analysis.  
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Figure 2.1. Depletion of SENP1/SENP2 does not globally perturb trafficking 
machinery. (A) Hela cells were treated with two independent sets of siRNA 
against SENP1, SENP2 or both  or scramble oligo (scm) of the first SENP2 oligo 
for 48hr. Cell lysates were subjected western analysis with antibodies against 
SENP1 and SENP2.  Levels of Importin b were monitored as a loading control. 
(B) siRNA-treated cells were subjected to indirect immunofluorescence analysis 
using antibodies against HSP70, Exportin1 (B), Transportin, RCC1, CAS (C), 











Figure 2.2. Depletion of SENP1/SENP2 perturbs the localization of RanGAP1. 
Hela cells were treated with  siRNA against SENP1, SENP2 or both for 48hr before 





Figure 2.3. Depletion of SENP1/SENP2 perturbs localization 
of SUMO1. Hela cells were treated with two independent sets of 
siRNA against SENP1, SENP2 or both for 48hr before indirect 




Figure 2.4. Depletion of SENP1/SENP2 perturbs localization 
of T7-SUMO1. Hela cells that stably expressed T7-tagged 
SUMO1 or SUMO3 were treated with siRNA against SENP1, 
SENP2 or both for 48hr and then subjected to indirect 




Figure 2.5. Depletion of SENP1/SENP2 perturbs the NPC targeting of 
Ubc9 and RanBP2. Hela cells  were treated with siRNA against SENP1, 
SENP2 or both for 48hr and then subjected to indirect 




Figure 2.6. Depletion of SENP1/SENP2 perturbs the NPC targeting of RanBP2 
and Nup62. Hela cells  were treated with siRNA against SENP1, SENP2 or both for 
48hr and then subjected to indirect immunofluorescence analysis using antibodies 





Figure 2.7. Depletion of SENP1/SENP2 perturbs the NPC targeting of Nup62 but 
not Nup153 and Pom121.  Hela cells or Hela stably expressing GFP-Pom121 were 
treated with siRNA against SENP1, SENP2 or both for 48hr and then subjected to 




Figure 2.8. SENP1/SENP2 bind to Nup153 and regulate its SUMOylation. (A) GFP 
(-) or GFP fusion proteins of SENP1 (SP1) and SENP2 (SP2) and their catalytic dead 
counterparts (CD) were expressed in Hela cells for 24hr before being harvested for GFP 
recovery followed by western analysis using antibodies against Nup153, Nup50, Nup62, 
and GFP. (B) A Hela cells that stably express T7-tagged SUMO3 were treated with 
siRNA against SENP1 (SP1), SENP2 (SP2), or both (SP1/2) for 48hr before being 
subjected to Nup153 immunoprecipitation followed by western analysis using antibodies 
against T7, Nup153, SENP1, and SENP2. (C) Flag-tagged fusion protein of catalytic 
dead SENP2 was coexpressed with either T7-tagged SUMO1 (S1), SUMO2 (S2), or 
SUMO3 (S3) in Hela cells. After 24hr, Nup153 was immunoprecipitated from cell lysates 













Figure 2.9. Nup153 has a bimodal interaction with SENP1 and SENP2. Flag-tagged 
fusion proteins of Nup153 N- and C-terminal domain (A) or zinc finger domain (B) were 
coexpressed with GFP (-) or GFP fusion proteins of SENP1 (SP1) or SENP2 (SP2) in 
Hela cells. After 24hr, GFP fusion proteins were recovered from cell lysates followed by 




Figure 2.10 Characterization of C-terminal domain interaction with SENP1 and 
SENP2. (A) GFP (-) or GFP fusion proteins of various C-terminal domain constructs 
were expressed in Hela cells for 24hr. GFP proteins were then captured, followed by 
western analysis using antibodies against SENP1, SENP2, Importin a, and GFP. The 
amino acid localization fo the various C-terminal domain truncations is listed in the box.  
(B) The sequence of C-terminal domain proximal and distal ends is presented with the 
FG repeats aligned vertically (green).  The basic residues (yellow), acidic residues 
(purple), and proline residues (blue) are highlighted in the linker regions. The Importin a 




Figure 2.11. The N-terminal domain of Nup153 has a SUMO-mediated interaction 
with SENP1/SENP2. (A) Flag fusion proteins of N-, zinc finger, and C-terminal domain 
were coexpressed with GFP fusion proteins of SENP1 (SP1) or catalytic dead SENP1 
(SP1 CD) in Hela cells for 24hr. Cell lysates were then subjected to western analysis 
using antibodies against Flag, GFP, and Nup153.  Arrow indicates SUMOylated N-
terminal domain. (B) Flag fusion proteins of N- and C-terminal domain were coexpressed 
with GFP fusion proteins of SENP1 (SP1), SENP2 (SP2) or their catalytic dead 
counterpart (CD) in Hela cells for 24hr. GFP proteins were then recovered from cell 




Figure 2.12. Nup153 is a unique target of SENP1 and SENP2. (A) Flag fusion 
proteins of SENP1 (SP1) or catalytic dead SENP1 (SP1 CD) were expressed in Hela cells 
for 24hr. Cell lysates were then harvested for western analysis using antibodies against 
indicated proteins.  (B) GFP fusion proteins of SENP1 (SP1), SENP2 (SP2) or SENP3 
(SP3), as well as their catalytic dead counterparts (CD) were expressed in Hela cells for 
24hr. Cell lysate were then harvested for western analysis using antibodies against 




Figure 2.13.  Disruption of Nup153 leads to NPC assembly defect. Hela cells were 
treated with siRNA against Nup153 or Nup50 for 48hr and then subjected to indirect 
immunofluorescence analysis using antibodies against RanGAP1 and TPR (A), Ubc9, 




Figure 2.14. Depletion of Nup153 perturbs the 
assembly of Nup133, Nup62 but not Pom121. Hela 
cells (A) or GFP-Pom121 stable Hela line (B) were 
treated with siRNA against Nup153, Nup50, or 
SENP1/SENP2 for 48hr and then subjected to indirect 
immunofluorescence analysis using antibodies against 




Figure 2.15. Depletion of Nup153 with an independent oligo results in NPC 
assembly defect. Hela cells were treated with an independent siRNA against Nup153 
for 48hr and then subjected to indirect immunofluorescence analysis using antibodies 
against Nup153, Nup62, and RanBP2. 
CHAPTER 3 
 





Nup153 and SENP1/SENP2 have been uncovered in this study to regulate NPC 
biogenesis; however, the molecular mechanisms behind this regulation pathway remain 
unclear. Nup153 interacts with and is SUMO regulated by SENP1/SENP2. Here, a 
SUMOylation site in Nup153 has been mapped to the lysine 353 in its N-terminal domain. 
Nup153 is found to interact stably with the SUMO E2 conjugating enzyme Ubc9. Such 
interaction is likely relevant in mediating the SUMOylation of Nup153 and may also be a 
determinant for Ubc9 localization to the NPC basket. While Nup153 SUMOylation is 
found to mediate enhanced interaction with SENP1/SENP2, this modification does not 
appear to affect Nup153 interaction with its binding partner TPR or its localization to the 
NPC or post-mitotic NPC assembly site. Interestingly, Nup153 and SENP1/SENP2 are 
found to have a mutual dependency for stability. In addition, proper assembly of the post-
mitotic nuclear basket is critical for the recruitment of SENP1. SENP1 and SENP2 are 
themselves targets of SUMOylation, regulated by their own catalytic activities. The 
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SUMOylation site of SENP2 is mapped to lysine 48 at its N-terminal domain, where 
SUMOylation may regulate nuclear localization. SENP1/SENP2 specificities in SUMO  
paralog targeting and their role in cell cycle progression are also further characterized in 
this study.   
3.2 Characterization of Nup153 SUMOylation 
 
3.2.1 Nup153 SUMOylation is cell cycle specific 
 
Nup153 has been reported to play roles throughout the cell cycle. In interphase, 
Nup153 is known to mediate nucleocytoplasmic trafficking through its interaction with a 
variety of trafficking receptors. Nup153 has also been reported in Drosophila to play a 
role in dosage compensation and transcriptional regulation (Mendjan et al., 2006; 
Vaquerizas et al., 2010). In addition, Nup153 has been described to play mitotic roles. 
Using nuclei assembled from Xenopus egg extract, Nup153 was shown to facilitate 
mitotic disassembly of the nuclear envelope, through a role in recruiting the COPI 
coatomer complex (Liu et al., 2003; Prunuske et al., 2006). Depletion of Nup153 in Hela 
cells was found to result in prolonged mitotic progression with delayed cytokinesis and 
multinucleated cells (Mackay et al., 2009). A link between the role for Nup153 in NPC 
basket assembly and an Aurora B-mediated abscission checkpoint was later established 
(Mackay et al., 2010). Collectively, these observations highlight the multifunctional 
nature of Nup153 throughout the cell cycle. A major question is that of how Nup153 
transitions between its various functions. 
 Posttranslational modification is likely to contribute to the switch to certain roles. 
For instance, phosphorylation at mitosis may alter Nup-Nup interactions and 
downregulate Nup153’s role in the architecture of the NPC basket. SUMOylation is 
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another posttranslational modification that is a good candidate for modulating Nup153 
function. To probe for a functional role of Nup153 SUMOylation, we sought to 
determine the window during the cell cycle when Nup153 is SUMOylated. To this end, 
Hela cells that stably express T7-tagged SUMO3 were arrested at metaphase using 
nocodazole. Metaphase-arrested cells were harvested and released into fresh media. Cell 
lysates were generated from these metaphase-arrested cells, cells 3 hr post-nocodazole 
release, or asynchronized cells. Nup153 was then immunoprecipitated and subjected to 
western analysis using anti-T7 antibody to determine Nup153 SUMOylation status. As 
shown in Figure 3.1, Nup153 SUMOylation is detected in asynchronous cells as well as 
cells 3 hr post-nocodazole release. In contrast, no SUMOylation of Nup153 is detected in 
metaphase-arrested cells, suggesting Nup153 SUMOylation is likely to function in post-
mitotic or interphase events and is prevented at the time of mitosis itself.  
3.2.2 The nuclear pore SUMO E3 ligase RanBP2/Nup358 
does not mediate Nup153 SUMOylation 
 
A constituent of the NPC cytoplasmic fibrils, RanBP2/Nup358, has been reported 
to have SUMO E3 ligase activity (Pichler et al., 2002), raising the possibility that 
RanBP2 may SUMOylate components of the NPC, including Nup153. To test this 
possibility, a siRNA against RanBP2 was used to deplete RanBP2 and a catalytic dead 
SENP1 construct was overexpressed to interfere with endogenous SENP activities. As 
shown in Figure 3.2, dominant interference of endogenous SENP activities by the 
catalytic dead SENP1 reveals the SUMOylation of Nup153 (Figure 3.2, lane 4-6). 
Treatment of RanBP2 siRNA efficiently downregulated the level of RanBP2. Yet, 
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concurrent depletion of RanBP2 failed to reduce levels of Nup153 SUMOylation, 
indicating that the SUMO E3 ligase RanBP2 is not required for Nup153 SUMOylation.  
3.2.3 Nup153 interacts with the SUMO E2 conjugating enzyme Ubc9 
 
Ubc9 has been reported localized to both the cytoplasmic fibrils and the nuclear 
basket of the NPC by immuno-electronmicroscopy (Zhang et al., 2002). Ubc9 is known 
to form a complex with RanGAP1 and RanBP2 at the NPC cytoplasmic fibrils; however, 
the binding partner of Ubc9 at the NPC nuclear basket is still uncharacterized. With the 
finding that Nup153 is a SUMO target, it is likely that Nup153 provides at least a 
transient binding platform for Ubc9. To test this hypothesis, GFP or a GFP fusion protein 
of Ubc9 was expressed in Hela cells and GFP proteins were isolated on an affinity matrix. 
As expected, RanBP2 was recovered with GFP-Ubc9 (Figure 3.3). Interestingly, the 
nuclear basket Nup153 but not another basket component TPR, was also found in 
association with Ubc9 (Figure 3.3), suggesting that Nup153 may serve as a binding 
platform for Ubc9 at the NPC nuclear basket. 
3.2.4 Perturbation of Nup153 deregulates SUMOylation 
 
Since Nup153 can interact with SENP1, SENP2, and Ubc9, it is possible that 
Nup153 functions as a SUMO enzyme scaffold to regulate the SUMOylation / 
deSUMOylation of specific target(s) at the NPC. To test this possibility, Nup153 was 
depleted through siRNA treatment and overall SUMOylation activity was probed by 
western analysis using SUMO1 and SUMO2/3 antibodies. While the pattern of targets 
was largely unaffected, depletion of Nup153 but not RanBP2 led to the accumulation of a 
specific SUMO1 band migrating at around 140kD (Figure 3.4). Interestingly, depletion of 
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another nuclear basket component, Nup50, resulted in the accumulation of a similar 
SUMO1 band (Figure 3.4) which persisted when the SUMO E3 ligase RanBP2 was 
codepleted (Figure 3.4 lanes 5, 6). While Nup153 is related to the SUMO pathway 
through its interaction with SENP1, SENP2, and Ubc9, it is unclear how Nup50 exerts a 
regulatory role on the SUMO modification pathway. No significant perturbation of 
SUMO2/3 modification was observed under these experimental conditions (not shown).  
3.2.5 Lysine 353 in the unique Nup153 N-terminal domain 
is a SUMOylation site 
 
The observation that SUMOylated Nup153 can associate robustly with catalytic 
dead SENP1/SENP2 (see Chapter 2) suggests that SUMO modification of Nup153 may 
be a recruitment signal for interaction with SENP1/SENP2. SENP2 has been previously 
shown to interact with the C-terminal domain of Nup153. Both the N- and C-terminal 
domains of Nup153 harbor a predicted SUMO consensus site, specifically amino acids 
352-355 and amino acids 1070-1073, but SUMOylation is detected only in the N-
terminal domain of Nup153 (see Chapter 2). Mutating lysine 353 to arginine (K353R) 
within the predicted SUMO consensus site of Flag fusion protein of Nup153 N-terminal 
domain abolished its SUMOylation when coexpressed with catalytic dead SENP1 (Figure 
3.5A). A similar pattern was observed with Flag-tagged fusion proteins of full-length 
Nup153 (Figure 3.5B) or Nup153 devoid of its C-terminal domain (Figure 3.5A), 
indicating that lysine 353 of Nup153 is a bone fide SUMOylation site and is the major 




3.2.6 SUMOylation on lysine 353 modulates Nup153 interaction  
with SENP1/SENP2 
 
To confirm that the SUMO-modified Nup153 N-terminal domain has an enhanced 
interaction with SENP1, we tested the sensitivity of this interaction to mutation of lysine 
353. As shown in Figure 3.6A, a GFP fusion protein of catalytic dead SENP1 robustly 
co-isolates with the SUMOylated HA-tagged Nup153 N-terminal domain; however, the 
K353R mutation abrogates the SUMOylation of N-terminal domain and the enhanced 
interaction with SENP1. To further verify a role of lysine 353 in mediating Nup153 
interaction with SENP1, GFP fusion proteins of Nup153 N-terminal domain (GFP-N), 
either wildtype or harboring a K353R mutation, were tested for ability to associate with 
Flag-tagged catalytic dead SENP1. As shown in Figure 3.6B, western analysis of the 
isolated GFP proteins with anti-Flag antibody revealed association between GFP-N and 
the catalytic dead Flag-SENP1. However, K353R mutation of GFP-N drastically reduces 
its interaction with catalytic dead Flag-SENP1. Collectively, these observations suggest 
that while SENP1/SENP2 can interact with both the N- and the C-terminal domain of 
Nup153, lysine 353 SUMOylation may provide an additional signal for dynamic 
recruitment of SENP1/SENP2 to the N-terminal domain of Nup153. Moreover, the 
results of Figure 3.6B, in which SENP1 does not bind to Nup153 N-terminal domain 
when SENP1 itself is modified, underscores another potential mechanism for regulating 
this interaction. 
3.2.7 Nup153 SUMOylation does not modulate its interaction with TPR 
 
The Nup153 N-terminal domain has been previously reported to have interactions 
with numerous proteins, as well as RNA, at regions close to lysine 353 (Ball and Ullman, 
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2005). Thus, one hypothesis is that SUMOylation of Nup153 modulates its repertoire of 
partners. To test this possibility, we determined whether the absence of Nup153 
SUMOylation affects its binding with TPR, a nucleoporin previously reported to bind to 
the N-terminal domain of Nup153. As shown in Figure 3.7A, a GFP fusion protein of the 
Nup153 N-terminal domain harboring the K353R mutation still interacts with TPR, 
suggesting that SUMOylation is not required for TPR interaction. However, this does not 
rule out the possibility that Nup153 SUMOylation can block the binding of TPR. Since 
SUMOylation is a highly dynamic process in vivo, it is difficult to recover sufficient 
SUMOylated Nup153 for a binding assay with TPR. To circumvent this problem, a 
bacterial SUMOylation system (Saitoh et al., 2009) was employed to generate 
SUMOylated Nup153. To this end, a minimal fragment of Nup153 N-terminal domain 
(amino acid 245-400) that is sufficient to bind to TPR was coexpressed in E. coli as a 
GST fusion protein (GST-N) together with SUMO E1 activation enzymes, SUMO E2 
conjugation enzyme, and SUMO1. As shown in Figure 3.7B, more than 50% of the 
affinity purified GST-N is SUMOylated in this system. In contrast, the GST fusion of 
Nup153 zinc finger domain (GST-Z) is not SUMOylated in this system. In addition, 
mutation of K353R within GST-N completely abolishes SUMOylation in this system, 
indicating it is specific to the bone fide SUMO site. To test whether SUMOylated GST-N 
can still interact with TPR, Hela cell lysate was incubated with these affinity purified 
GST fusion proteins and TPR then immunoprecipitated. As shown in Figure 3.7C (lanes 
4, 5), both SUMOylated and unSUMOylated GST-N similarly recover with TPR, 





3.2.8 Nup153 K353R localizes properly to the interphase nuclear envelope  
and to post-mitotic telophase NPC assembly sites 
 
Previous studies have mapped the nuclear envelope and nuclear pore targeting 
motifs of Nup153 to its N-terminal domain, at aa 2-144 and aa 39-339 respectively 
(Bastos et al., 1996; Enarson et al., 1998). To determine if SUMOylation of Nup153 
regulates pore targeting, we examined the nonSUMOylatable mutant of Nup153 N-
terminal domain for its intracellular localization. A GFP fusion protein of Nup153 N-
terminal domain (GFP-N) expressed in Hela cells localizes to nuclear envelope in 
interphase cells (not shown) and appears at post-mitotic pore assembly site (Figure 3.8). 
Mutating lysine 353 does not lead to any significant perturbation in localization (Figure 
3.8), suggesting that Nup153 SUMOylation may not be required for pore targeting of 
Nup153. 
3.3 Characterization of SENP1 and SENP2 SUMO regulation 
 
3.3.1 SENP1 and SENP2 differ in affinity toward SUMO targets 
 
SENP1 and SENP2 are the only reported SUMO proteases to localize at the 
vertebrate NPC. Studies from animal models and tissue culture systems have highlighted 
nonredundant functional roles of SENP1 and SENP2. To further understand if SENP1 
and SENP2 differ in their SUMO regulation of potential NPC targets, the binding 
affinities of SENP1 and SENP2 towards various SUMO paralogs were characterized. The 
C602S and C549S mutations on SENP1 and SENP2 can, respectively, inactivate their 
deSUMOylation activities (catalytic dead) but do not block their interactions with SUMO 
targets. These mutants are therefore suitable for characterizing the SUMO paralog 
targeting specificity of SENP1 and SENP2. To this end, GFP fusion proteins of wildtype 
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and catalytic dead mutants of SENP1 and SENP2 were expressed in Hela cells. GFP 
fusion proteins along with associated proteins were recovered from cell lysates and 
subjected to western analysis using SUMO1 or SUMO2/3 antibodies. As shown in Figure 
3.9 (left panel), SENP1CD interacts robustly with both SUMO1 and SUMO2/3-modified 
proteins, consistent with the ability of SENP1 WT to remove both SUMO1 and 
SUMO2/3 (see input lanes). While SENP2 CD displayed similar strong affinity towards 
SUMO2/3-modified proteins, it shows only weak interaction with SUMO1 targets. 
Consistent with preferred targeting SUMO2/3, SENP2 WT strongly deSUMOylates 
SUMO2/3-modified proteins and exerts weak deSUMOylating activity towards SUMO1 
modification. The differences of SUMO paralog specificity of SENP1 and SENP2 is 
further exemplified by examining the SENP1/SENP2 targeting of a major SUMO1 target, 
RanGAP1. As shown in Figure 3.9 (right bottom panel), SENP1, but not SENP2, can 
bind and deSUMOylate SUMO1-modified RanGAP1. Collectively, these data indicate 
that while SENP1 and SENP2 can localize to the NPC (possibly through Nup153), they 
differentially discriminate among SUMO substrates.  
3.3.2 SENP1 and SENP2 are both targets of SUMO modification 
 
SENP1 and SENP2 share a similar C-terminal catalytic domain but differ within 
their N-terminal domains, which likely contribute to their targeting specificity towards 
various SUMO substrates. It is reported that SENP2 is expressed in various isoforms that 
include truncation of its N-terminal domain (Nishida et al., 2001; Best et al., 2002; 
Kadoya et al., 2000; Jiang et al., 2010). These SENP2 isoforms display changes in 
localization and substrate targeting. No isoform variation has been reported for SENP1, 
but SENP1 has been reported to be SUMO modified when its catalytic activity is 
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inactivated (Bailey and O’Hare, 2004), suggesting that its deSUMOylating activity may 
regulate its own SUMO modification status. The SUMO modification site however has 
never been mapped and the functional role of this SUMO modification is not known. 
Nonetheless, SENP1 SUMOylation offers a possible regulatory mechanism for its 
function. We therefore sought to determine whether the NPC-associated SUMO proteases 
SENP1 and SENP2 are uniquely regulated by SUMO modification. To this end, catalytic 
dead mutants of SENP1, SENP2, and a nucleoli-localized SENP3, as well as their 
wildtype counterparts, were expressed as GFP fusion proteins in Hela cells and subjected 
to western analysis using a GFP specific antibody. As shown in Figure 3.10A, both the 
catalytic dead SENP1 and SENP2 GFP fusion proteins display protein mobility shifts 
indicative of possible SUMOylation. In contrast, the nucleoli-associated SENP3 showed 
no sign of being post-translationally modified. To verify that the shifted species of 
catalytic dead SENP1 and SENP2 are SUMO-modified species, these GFP fusion 
proteins were coexpressed with T7-tagged SUMO1 or SUMO2 and recovered from cell 
lysates. The samples were then probed for SUMO by western analysis using T7 antibody. 
As shown in Figure 3.10B, catalytic dead SENP1 is found to be modified by both 
SUMO1 and SUMO2; however, catalytic SENP2 appeared to be modified by SUMO2 
alone, further underscoring the SUMO paralog specificity of SENP1 and SENP2, and 
confirming that NPC-associated SUMO proteases are targets of SUMO modification.  
3.3.3 Characterization of SENP2 SUMOylation 
 
To further probe for a functional role of SENP2 SUMOylation, we sought to map 
the SUMOylation site of SENP2. As shown in Figure 3.11A, mutation of lysine 48 to 
arginine (K48R) can significantly block the SUMOylation of catalytic dead SENP2. 
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Interestingly, K48R mutant of SENP2 also displayed lack of stability and localized to the 
cytoplasm (Figure 3.11B). The cytoplasmic mislocalization of K48R SENP2 mutant 
suggests that SUMOylation at lysine 48 may be important for nuclear localization of 
SENP2. A previous study indicated that forced cytoplasmic localization of SENP2 can 
lead to its ubiquitylation and degradation (Itahana et al., 2006). The instability of K48R 
SENP2 mutant may be indicative of a cytoplasmic ubiquitin-mediated degradation. 
Further characterization is required to determine how lysine 48 SUMOylation regulates 
SENP2 nuclear localization.  This study as well as a previous study has attempted to map 
the SUMOylation site of SENP1. Mutating lysine 568 at the predicted consensus site 
(Bailey and O’Hare, 2004), as well as lysines at nonSUMO consensus sites (lysines 574, 
575, 577, 589, 590, 616, 632) did not abrogate SENP1 SUMOylation (not shown). 
Further mutagenesis analysis at other nonSUMO consensus sites is required for map the 
SUMOylation site of SENP1.  
3.3.4 A role of SENP2 in metaphase progression 
 
Zhang et al. reported that overexpression of SENP2 can lead to prometaphase 
arrest, possibly due to its regulatory activity towards the targeting of factors to 
kinetochore (Zhang et al., 2008). When probing for a functional difference between 
SENP1 and SENP2, we discovered that siRNA depletion of SENP2 leads to 
accumulation of metaphase arrested cells (Figure 3.12). In contrast, depletion of SENP1 
or Nup153 does not block metaphase progression, suggesting a specific role of SENP2 in 
metaphase progression. It is unclear whether SENP2 depletion can lead to 
hyperSUMOylation of BubR1 and Nuf2 whose SUMOylation have been proposed to be 
important for the recruitment of the microtubule motor protein CENPE to the kinetochore 
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(Zhang et al., 2008).  In addition, these analyses were performed with only one set of 
siRNA oligo against individual target; the observation needs to be further verified with an 
independent siRNA oligo.  
3.4 Mutual dependency of Nup153, SENP1, and SENP2 for stability 
 
3.4.1 Downregulation of Nup153 destabilizes SENP1 
 
Previous studies in yeast have indicated that mutations within the 
Nup60/Mlp1/Mlp2 complex or the Nup84 complex destabilize Ulp1 and mislocalize 
Ulp1 into perinuclear aggregates (Zhao et al., 2004; Palancade et al., 2007). With our 
findings that SENP1 and SENP2 can interact with Nup153 at the NPC, it was thus of 
interest to determine whether disruption of Nup153 perturbs the stability and/or 
localization of SENP1 and SENP2. To this end, Nup153 was RNAi depleted, followed 
with analysis by indirect immunofluorescence analysis using antibody against SENP1 
(antibodies to endogenous SENP2 suitable for immunofluorescence are not currently 
available). As shown in Figure 3.13A, severe depletion of Nup153 leads to deformation 
of the nuclear envelope as previously reported (Mackay et al., 2009). However, SENP1 is 
still detected at the nuclear envelope of interphase cells. Since residual levels of Nup153 
are still present at the nuclear envelope after the siRNA treatment, it is difficult to rule 
out that this population of Nup153 is sufficient to maintain the localization of SENP1 at 
the pore. However, what was clear is that the overall staining intensity of SENP1 is 
drastically decreased upon the depletion of Nup153 (Figure 3.13A), indicative of SENP1 
destabilization. To verify this possibility, western analysis of SENP1 was performed. As 
shown in Figure 3.13B, SENP1 antibody detects two bands migrating at slightly different 
mobilities. Both bands are depleted upon treatment with two independent siRNA oligos 
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of SENP1, indicating that they reflect isoforms of SENP1 or SENP1 molecules with 
different post-translational modification. Interestingly, RNAi depletion of Nup153 
resulted in significant downregulation of SENP1 but not SENP2 (Figure 3.13C), 
suggesting a role of the nuclear basket protein Nup153 in stabilizing SENP1. Since we 
have also detected interaction between SENP1 and the NPC cytoplasmic fibril 
component RanBP2, we examined whether depletion of RanBP2 can similarly destabilize 
SENP1. RNAi depletion of RanBP2 did not downregulate SENP1 (Figure 3.13C), 
indicative of a specific role for Nup153 in stabilizing SENP1. Previous studies have 
shown that severe downregulation of Nup153 can also destabilize and mislocalize a 
number of nuclear basket nups, including Nup50 and TPR (Hase and Cordes, 2003). To 
determine whether the destabilization of SENP1 upon Nup153 depletion can be attributed 
to alterations of Nup50 or TPR, we performed RNAi depletion against these nups. As 
shown in Figure 3.13D, depletion of TPR leads to only minor downregulation of SENP1 
and depletion of Nup50 has no effect on SENP1 stability, highlighting Nup153 as the 
predominant player at the nuclear basket in stabilizing SENP1.  
3.4.2 SENP1 and SENP2 contribute to Nup153 stability 
 
As described in Chapter 2, codepletion of SENP1 and SENP2 results in a similar, 
albeit less severe, NPC biogenesis defect compared to Nup153 depletion. This leads to 
the possibility that SENP1, SENP2, and Nup153 work in a common pathway in NPC 
biogenesis. Since SENP1 and SENP2 can regulate the SUMOylation of Nup153, it is 
possible that codepletion of SENP1/SENP2 leads to a SUMO-mediated downregulation 
of Nup153, which in turn, contributes to defects in NPC biogenesis. To test this 
possibility, levels of Nup153 were examined upon the depletion of SENP1 and SENP2. 
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As shown in Figure 3.14A, B, using two independent oligo sets, single depletion of 
SENP1 or SENP2 did not affect the stability of Nup153; however, codepletion of SENP1 
and SENP2 resulted in a partial but reproducible decrease in Nup153 level. While it is 
unclear whether SENP1 and SENP2 mediate NPC biogenesis through regulating the 
stability of Nup153, these observations collectively suggest an interesting mutual 
dependency of Nup153, SENP1, and SENP2 for stability.  
3.4.3 Post-mitotic assembly defect leads to mislocalization of SENP1 
 
Mackay et al. have previously reported that mild downregulation of Nup153 can 
lead to defect in post-mitotic nuclear basket assembly, with mislocalization of numerous 
nuclear basket nups in the cytoplasm of cells undergoing cytokinesis. To determine 
whether SENP1 NPC localization is affected by a post-mitotic defect of nuclear basket 
assembly, cells that were mildly depleted of Nup153 were subjected to indirect 
immunofluorescence using antibodies against SENP1 and tubulin, which marks the 
midbody structure of cells undergoing cytokinesis. As shown in Figure 3.15A, mild 
depletion of Nup153 did not mislocalize SENP1 in interphase cells; however, 
cytoplasmic mislocalization of SENP1 was observed in cells undergoing cytokinesis as 
indicated by the tubulin midbody structure. Since depletion of Nup153 is known to 
mislocalize multiple nuclear basket components, including Nup50 and TPR, in midbody-
staged cells, our observations suggest that functional nuclear basket assembly is required 
for the post-mitotic recruitment of SENP1. Consistent with this interpretation, dominant 
interference of post-mitotic nuclear basket assembly by overexpression of Nup153 C-
terminal domain (Mackay et al., 2010) similarly leads to cytoplasmic delocalization of 
SENP1 in cells undergoing cytokinesis (Figure 3.15B). In contrast, overexpression of 
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Nup153’s N-terminal domain or zinc finger domain did not lead to delocalization of 
SENP1 (Figure 3.15B). We failed to detect delocalization of SENP1 upon severe 
depletion of Nup153 in interphase cells (see Figure 3.13A), but did observe significant 
downregulation of SENP1 levels (see Figure 3.13B, C, D). Thus, it is possible that 
SENP1 was in fact delocalized into nucleoplasm/cytoplasm in the absence of Nup153 but 
rapidly degraded. Collectively, these findings suggest that binding determinant(s) at the 
nuclear basket, such as Nup153, play an important role in the localization and stability of 
SENP1.  
3.4.4 Cdk1/Cdk2 inhibition delocalizes components of cytoplasmic fibril  
and downregulates SENP1 and SENP2 
 
Interphase NPC assembly has been recently reported to be regulated by 
Cdk1/Cdk2 (Maeshima et al., 2010). Inhibition of Cdk1/Cdk2 with roscovitine led to 
colocalization of multiple nucleoporins, including Nup62, Nup133, and Nup107 in 
cytoplasmic foci. Interestingly, the transmembrane Nup Pom121 and the nuclear basket 
component Nup153 were not delocalized upon Cdk1/Cdk2 inhibition. While this study 
did not address whether Cdk1/Cdk2 inhibition can also delocalize components of 
cytoplasmic fibrils of the NPC (RanGAP1, Ubc9, RanBP2), the reported observations 
share striking similarity with our findings that Nup62 and Nup133, but not Pom121 and 
Nup153, show accumulation of cytoplasmic foci upon codepletion of SENP1 and SENP2. 
These findings suggest that Cdk1/Cdk2 and SENP1/SENP2 may share a common 
regulatory pathway in interphase NPC biogenesis. As shown in Figure 3.16, we found 
that inhibition of Cdk1/Cdk2 for 16 hr by roscovitine significantly downregulates SENP2 
levels while SENP1 exhibited only subtle downregulation. Roscovitine treatment has also 
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been reported to decrease expression of numerous nucleoporins including Nup153 
(Maeshima et al., 2010). Thus, the defective interphase NPC biogenesis induced by 
Roscovitine treatment may be due to the downregulation of SENP1/SENP2 or Nup153 or 
both, as depletion of these proteins leads to similar pattern of defective NPC biogenesis. 
3.5 Conclusions 
 
In this study, the NPC-associated SUMO proteases and the nucleoporin are found 
to be target of SUMOylation. The presence of SUMO proteases at the vicinity of the NPC 
is likely to confer functional regulation on NPCs. However, we failed to correlate the 
SUMO regulation of Nup153 to its interaction with the nuclear basket component TPR. 
In addition, SUMOylation does not modulate Nup153 localization at the NPC. 
Nonetheless, we have found a function of Nup153 SUMOylation in modulating 
interaction with SENP1/SENP2, opening a gateway for its role in the SENP1/SENP2-
mediated regulation of NPC biogenesis. Interestingly, the SENP1 and SENP2 are 
themselves targets of SUMOylation, leading to the possibility that self-deSUMOylation 
or trans-deSUMOylation among SENP1 and SENP2 may regulate their SUMOylation 
status. While it is unclear what the main regulatory purpose of SENP SUMOylation is, 
we have found that SUMOylated SENP1 displays compromised binding to Nup153 and 
nonSUMOylatable SENP2 displays defective nuclear localization, opening new doors in 
understanding the regulatory mechanism of the SENPs. We have also uncovered that 
Nup153 is a binding platform for both the SUMO conjugation machinery Ubc9 and the 
deconjugation machinery SENP1/SENP2. These findings lead to an interesting possibility 
that Nup153 may coordinate the dynamic SUMO conjugation and deconjugation of 
interacting proteins at the nuclear basket, including the SENPs and Ubc9 whom are all 
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targets of SUMOylation. In support of this possibility, we have found that depletion of 
the nuclear basket components Nup153 or Nup50 lead to aberrant accumulation of 
specific SUMO1 substrate. With the finding the Nup153 and SENP1/SENP2 could be 
downstream of the Cdk1/Cdk2 activity, the nuclear basket could be a busy hub where 
various enzymatic activities converge to regulate the myriad of activities of NPCs.  
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Figure 3.1 Nup153 SUMOylation is abrogated upon metaphase arrest. Hela 
cells that stably express T7-SUMO3 were treated with nocodazole overnight.  Cells 
arrested at metaphase were collected and released into fresh media for 0hr or 3hr.  
Asynchronous cells (Asyn), as well as metaphase arrested cells (0h) and cells 3hr 
post nocodazole release (3h) were lysed for Nup153 immunoprecipitation followed 
by western analysis using antibodies against T7, Nup153, Importinß, SENP1 and 




Figure 3.2 The SUMO E3 ligase RanBP2 does not mediate the SUMOylation of 
Nup153. Hela cells were transfected with RanBP2 siRNA for 24hr followed by the 
transfection of plasmid constructs of GFP (-), GFP-SENP1 (SP1), or GFP-SENP1 
catalytic dead (SP1 CD) for another 24hr. Cells were harvested and subjected to western 




Figure 3.3 Ubc9 interacts with Nup153.  Hela cells were transfected with plasmid 
constructs encoding GFP or GFP-Ubc9. After 24hr, cells were harvested and GFP fusion 
proteins were affinity purified followed by western analysis using antibodies against 




Figure 3.4 Depletion of Nup153 or Nup50 perturbs SUMO1 
modification. siRNA against Nup153, RanBP2, or Nup50 were transfected 
into Hela cells for 48hr. Cells were harvested for western analysis using 




Figure 3.5 Lysine 353 of Nup153 is the SUMOylation site.  (A, B) Flag 
contructs of Nup153 N-terminal domain (N), N-terminal domain with zinc 
finger domain (N+Z), or full-length Nup153 (FL), together with their K353R 
counterparts, were cotransfected with construct encoding GFP- catalytic dead 
SENP1 (SENP1CD) into Hela for 24hr. Cells were harvested for western 




Figure 3.6 SUMOylation of lysine 353 modulates Nup153 interaction with SENP1.  
(A) HA-tagged fusion proteins of the Nup153 N-terminal domain (HA-N) or its K353R 
counterpart (HA-N K353R) were cotransfected with a construct encoding GFP- catalytic 
dead SENP1 (SENP1CD) into Hela cells. After 24hr, GFP proteins were recovered from 
cell lysates followed by western analysis using antibodies against Flag and GFP.  (B) 
Flag-tagged fusion protein of catalytic dead SENP1 was coexpressed with GFP-tagged 
fusion proteins of Nup153 N-terminal domain (GFP-N) or its K353R counterpart (GFP-N 
K353R). After 24hr, GFP proteins were recovered from cell lysates and washed with 
washing buffer containing 1% Tx100 (a), or with addition of 0.1% Deoxycholate (b), or 





Figure 3.7 Nup153 SUMOylation does not modulate binding with TPR.  (A) GFP (-) 
or GFP fusion proteins of N-terminal domain of Nup153 (N), or its K353R counterpart (N 
K353R) were expressed in Hela cells. After 24hr, GFP proteins were recovered from cell 
lysates followed by western analysis using antibodies against TPR and GFP.  (B) 
Constructs encoding GST-tagged fusion protein of a TPR-binding fragment (aa 254-400) 
of N-terminal domain (N) or its K353R counterpart (NK353R) or the zinc finger domain 
(ZnF) were cotransformed with a polycistronic construct that encode the SUMO 
activation/conjugation enzymes (E1/E2) and SUMO1 into E. coli for protein expression.  
Affinity-purified GST proteins were subjected to western analysis using GST specific 
antibody. (C) Affinity purified GST fusion protein of ZnF, N, or NK353R were mixed 
with Hela cell lysates. TPR were then immunoprecipitated from lysates and subjected to 




Figure 3.8 SUMOylation of Nup153 is not required for its targeting to post-mitotic 
NPC assembly site. Flag-tagged fusion proteins of Nup153 N-terminal domain (N, panel 
at left) or its K353R counterpart (N K353R, panel at right) were expressed in Hela cells 
for 24hr. Cells were examined by indirect immunofluorescence analysis using antibodies 




Figure 3.9 SENP1 and SENP2 have targeting preference  for SUMO paralogs. GFP 
(-) or GFP fusion proteins of SENP1 (SP1), SENP2 (SP2) and their respective catalytic 
dead counterparts (CD) were expressed in Hela cells. After 24hr, GFP proteins were 
recovered followed by western analysis using antibodies against SUMO1, SUMO2/3, 




Figure 3.10 SENP1 and SENP2 are targets of SUMO modification. (A) GFP fusion 
proteins of SENP1 (SP1), SENP2 (SP2), or SENP3 (SP3), as well as their catalytic 
dead counterparts (CD) were overexpressed in Hela cells. After 24hr, cell lysates were 
then subjected to western analysis using antibody against GFP. (Part of this data was 
presented in Chapter 2 Figure 2.12B) (B) GFP fusion proteins of catalytic dead SENP1 
or SENP2 were coexpressed with T7-tagged fusion proteins of SUMO1 or SUMO2. 
After 24hr, GFP proteins were recovered from cell lysates and subjected to western 




Figure 3.11 Characterization of SENP2 SUMOylation. (A) GFP fusion protein of 
catalytic dead SENP2 (SP2CD) or its K48R counterpart was overexpressed in Hela 
cells. After 24hr, cell lysates were then subjected to western analysis using antibody 
against GFP.  Levels loaded were adjusted to have equal amount of unmodified SENP2 
protein. (B) GFP fusion protein of catalytic dead SENP2 (SP2CD) or its K48R 
counterpart was overexpressed in Hela cells. After 24hr, cells were subjected to 
immunofluorescence analysis using GFP-specific antibody. The GFP-SENP2CD 
decorates the nuclear rim as well as nucleoplasm, its K48R counterpart, however, 




Figure 3.12 Characterization of SENP2 SUMOylation. (A) Hela cells were treated 
with siRNA against SENP2. After 48hr, cell lysates were collected and subjected 
western analysis using antibodies against SENP2 and Nup153. (B, C) Hela cells were 
treated with siRNA against Nup153, SENP1 (SP1)or SENP2 (SP2). After 48hr, cells 
were subjected to indirect immunofluorescence analysis using tubulin-specific antibody 
(green) and DNA (blue) (B). Cells in midbody or metephase stage were quantified (C), 




Figure 3.13 Downregulation of Nup153 destabilizes SENP1. (A) Hela cells were 
treated with siRNA against Nup153 (or its scramble oligo) for 48hr, and were subjected 
to immunofluorescence analysis with antibodies against SENP1 (green) and Nup153 
(red). (B, C, D) Hela cells were treated with two independent sets of siRNA against 
SENP1 (B), or siRNA against Nup153, Nup358, TPR, and Nup50 (C, B). After 48hr, 





Figure 3.14 SENP1 and SENP2 regulate the stability of Nup153. 
(A, B) Hela cells were treated with two independent sets of siRNA 
oligos against SENP1 and SENP2, as well as Nup153 and Nup50, for 
48hr. Cell lysates were harvested and subjected to western analysis 




Figure 3.15A Post-mitotic nuclear basket assembly defect delocalizes 
SENP1. Hela cells were treated with siRNA against Nup153 or Nup50 (with 
control scramble). After 48hr, cells were subjected to indirect 
immunofluorescence using antibodies against tubulin (green) and SENP1 
(red), with DNA stained (blue). Midbody-staged cells are highlighed by 




Figure 3.15B Dominant interference of post-mitotic nuclear basket 
assembly disrupts SENP1 localization. Flag-tagged fusion proteins of 
Nup153 C- or N-terminal domain, as well as the zinc finger domain were 
overexpressed in Hela cells. After 24hr, cells were subjected to indirect 
immunofluorescence analysis using antibodies against SENP1 (green), 
Flag (red) and CRIK (red). [CRIK is a midbody marker stained as a red dot 
in-between cells undergoing cytokinesis indicated by yellow arrows; both 
the C-terminal domain and zinc finger domain have cytoplasmic 
localization while the N-terminal has nuclear rim and nucleoplasmic 
localization]. The DNA were stained in blue. Delocalized SENP1 is 
indicated by a small white arrow.   
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Figure 3.16 Inhibition of Cdk1/Cdk2 downregulates SENP1 and 
SENP2. Hela cells seeded at two density 25x104 or 45x104 cell/well were 
treated with the Cdk1/Cdk2 inhibitor roscovitine (ROS). After 16hr, cell 
lysates were subjected to western analysis using antibodies against SENP1, 
SENP2, and Importin b. 
CHAPTER 4 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
4.1 A role for SENP1 and SENP2 NPC biogenesis 
 
Previous studies from yeast and from mammalian tissue culture system have 
found numerous nucleoporins as well as nonnuclear pore components to contribute to 
interphase NPC biogenesis (Doucet and Hetzer, 2010), but little is known about the 
spatiotemporal control of this process. In this study, SENP1 and SENP2 are identified to 
have a regulatory role in NPC biogenesis, with the exciting implication that 
deSUMOylation activity at the nuclear envelope may regulate recruitment of 
nucleoporins to the NPC assembly site. A key question that remains to be verified is 
whether the catalytic activity of SENP1/SENP2 is required for this regulatory function. 
To determine this, siRNA resistant expression constructs of SENP1/SENP2 or their 
catalytic dead counterparts could be individually/dually transfected into SENP1/SENP2 
depleted cells and assess for their ability to rescue the NPC biogenesis defect. Nup153’s 
role in coordinating NPC biogenesis is proposed in this study to be mediated through its 
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interaction with SENP1/SENP2. Since the SUMOylation of Nup153’s N-terminal domain 
was shown to modulate its interaction with SENP1/SENP2, the above rescue strategy 
could also be employed to probe for a role of Nup153 SUMOylation in NPC biogenesis, 
specifically determining whether the nonSUMOylatable mutant K353R of Nup153 can 
rescue the NPC biogenesis defect induced through Nup153 depletion.  
4.2 Distinguishing between a de novo and a post-mitotic NPC assembly  
defect upon Nup153/SENP1/SENP2 depletion 
 
New NPCs are constantly assembled from newly translated nucleoporins and 
incorporated into the expanding nuclear envelope during interphase (de novo NPC 
assembly). In addition, existing nucleoporins present from NPCs that are disassembled 
during mitosis are reassembled at telophase (post-mitotic NPC assembly) (Doucet and 
Hetzer, 2010). While cytoplasmic delocalization of nucleoporins upon Nup153/SENP 
depletion is observed predominantly in G1/S cells, these phenotypes are not excluded 
from cells undergoing cytokinesis. Preliminary tracking of cells undergoing cytokinesis 
with G1 markers like phospho-Rb or PCNA (not shown) were not conclusive to 
distinguish whether these phenotypes are a reflection of a de novo NPC assembly defect 
as the NE becomes closed or a defect in post-mitotic NPC assembly. 
Makio et al. have previously employed a strategy to monitor de novo NPC 
synthesis through tracking nucleoporins fused to a photoactivatable fluorescent protein 
Dendra, which switches from green fluorescence to red upon exposure to visible blue 
light (Makio et al., 2009). Since depletion of Nup153/SENP leads to accumulation of 
Nup133 in cytoplasmic foci, a Dendra fusion protein of Nup133 would be an ideal 
reagent to distinguish de novo vs post-mitotic NPC assembly. Briefly, Hela cells stably 
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expressing the Dendra-Nup133 fusion protein would be subjected to live-cell imaging 
and cells at early stages of mitosis (prophase / metaphase) photoactivated to switch its 
green fluorescence to red, enabling us to track them as a mitotic disassembled nup 
population. The Dendra-red Nup133 would be tracked in these mitotic cells as they 
undergo cytokinesis untill entry to G1/S. If red cytoplasmic foci of these Dendra-red 
Nup133 fusion proteins appeared in cells undergoing cytokinesis (when post-mitotic NPC 
assembly occurs) upon the depletion of Nup153/SENP, then Nup153/SENP may have 
roles in mediating post-mitotic NPC assembly. However, if these Dendra-red Nup133 
population were properly assembled at post-mitotic NPC assembly sites with the 
appearance of newly translated Dendra-green Nup133 foci in cells undergoing 
cytokinesis and transitioning to early G1, this would be indicative of a de novo NPC 
assembly defect.  
4.3 Possible redundancy of SENP1 and SENP2 in NPC biogenesis 
 
In this study, depletion of SENP1 alone does not lead to NPC biogenesis defect 
whereas depletion of SENP2 can mildly deregulate the assembly of multiple nucleoporins. 
However, codepletion of SENP1 and SENP2 leads to a more severe NPC assembly defect. 
These observations suggest that SENP2 may be the predominant SUMO protease to 
mediate NPC biogenesis. However, in its absence, SENP1 may partially substitute for the 
role of SENP2 in deSUMOylating SUMO targets for NPC assembly regulation. In 
Chapter 3, SENP2 is demonstrated to have a bias toward binding/targeting SUMO2/3 
substrates; however, SENP1 can bind/target both SUMO1 and SUMO2/3 substrates. In 
addition, both SENP2 and SENP1 localize to the NPC and interact with the nuclear 
basket Nup153. Their overlapping SUMO paralog specificity and localization may 
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explain why SENP1 could partially substitute the function of SENP2. Such interpretation 
points toward that deSUMOylation of SUMO2/3-modified target(s) as an important 
regulatory event during NPC biogenesis. Since the catalytic domains of SENP1 and 
SENP2 are highly similar, the sequence divergence of their N-terminal domains could 
mediate specific recognition of regulatory targets during NPC biogenesis.  
4.4 Distinct requirements for recruiting and assembling cytoplasmic fibrils  
and nuclear basket of the NPC 
 
The basic architecture of NPC consists of the central nups core, the cytoplasmic 
fibrils, and the nuclear basket. Sequential recruitment of transmembrane and scaffolding 
nucleoporins to the assembly site has been illustrated by Doucet et al. that Pom121 
recruitment to the NPC assembly site precedes the scaffolding Nup107 complex during 
de novo assembly (Doucet et al., 2010). It is proposed that NPC assembly at the NE 
begins with the formation of a prepore structure by transmembrane nups that 
subsequently recruit the assembly of the core scaffolding nups and peripheral nups. The 
nucleated core scaffolding/peripheral nups will then recruit components that form the 
cytoplasmic fibril and nuclear basket structures (Doucet et al., 2010; Doucet and Hetzer, 
2010). Emerging evidence suggests that the central core nups independently recruit 
elements of the cytoplasmic fibrils and nuclear basket. A recent study from Makio et al. 
has demonstrated that disruption of Nup170 and Nup157 scaffolding nups in yeast leads 
to an assembly defect of cytoplasmic fibrils, while nuclear basket intermediates are still 
found to decorate INM sites that failed to fuse with ONM (Makio et al., 2009). In 
addition, depletion of the mammalian peripheral Nup98 specifically leads to assembly 
defects in components of cytoplasmic fibril but not components of the nuclear basket.  
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In this study, the depletion of SENP1/SENP2 is found to lead to assembly defects 
in the scaffolding/peripheral nups Nup133/Nup62, as well as the cytoplasmic fibril nup 
RanBP2. In contrast, components of the nuclear basket appear to undergo normal 
assembly upon SENP1/SENP2 depletion. These observations imply the dependency of 
cytoplasmic fibril assembly on the scaffolding/peripheral nups Nup133/Nup62. In 
contrast, the presence of Nup133/Nup62 may not be essential for the assembly of nuclear 
basket, suggesting that in the absence of SENP1/SENP2, the nuclear basket can be 
assembled without a complete scaffolding/peripheral core. Such a nuclear basket 
intermediate might be similar to the intermediate reported by Makio et al. that is 
associated with the INM at a site where fusion with the ONM is absent. Immunogold EM 
analysis of NPCs structures using antibodies against components of 
scaffolding/peripheral, cytoplasmic fibrils, and nuclear basket could be employed to 
address this hypothesis.  
To determine if the assembly of the scaffolding/peripheral nups Nup133/Nup62 is 
required prior to recruitment of the cytoplasmic fibrils, Nup133 and Nup62 could be 
depleted through RNAi and the assembly pattern of cytoplasmic fibril components such 
as RanGAP1 and RanBP1/Nup358 examined. If assembly of the scaffolding/peripheral 
core precedes the recruitment of cytoplasmic fibril components, Nup133/Nup62 depletion 
will likely lead to accumulation of RanGAP1 and RanBP1/Nup358 in cytoplasmic foci. 
In addition, disruption of the scaffolding/peripheral core through Nup133/Nup62 RNAi is 
not expected to perturb the assembly pattern of the nuclear basket.  
If these proposed experiments yield the predicted results, the observed assembly 
defects in scaffolding/peripheral nups and cytoplasmic fibrils upon SENP1/SENP2 
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depletion would suggest an upstream role of SENP1/SENP2 in mediating the assembly of 
scaffolding/peripheral nups, entailing the possibility that certain scaffolding/peripheral 
nups could be SUMO targets regulated by SENP1/SENP2. Indeed, dominant interference 
of SENP1 activity through overexpression of catalytic dead SENP1 resulted in Nup133 
SUMOylation (not shown). This dominant interference of SENP1/SENP2 approach may 
be a feasible method to systematically identify which of the scaffolding/peripheral nups 
could be SUMO targets regulated by SENP1/SENP2. A similar approach could be 
applied to examine potential SENP1/SENP2 regulation on nonnucleoporin factors 
identified to mediate NPC biogenesis such as the ER protein Rtn4, the trafficking factors 
Ran, Importin α, Importin β. Interestingly, some members of the scaffolding nups Nup43, 
Nup107, Nup133, Nup155, Nup205, and Nup93 (Vertegaal et al., 2006; Golebiowski et 
al., 2009; Blomster et al., 2009), as well as the trafficking factors Importin α, Importin β, 
and Ran (Nie et al., 2009; Rosas-Acosta et al., 2005; Matafora et al., 2009), have been 
previously identified in proteomic studies as potential SUMO targets (see Table 1.1 in 
Chapter 1). 
It is unclear how dynamic SUMOylation of nucleoporins could regulate the 
assembly process of NPC biogenesis. It is possible that the SUMOylation of Nup153, 
Nup133 or other nups can act as a switch to impose temporal regulation of their 
interactions with other nups/factors during NPC assembly. Such regulation may be 
important to prevent premature incorporation of newly translated nups to the NPC 
assembly sites. In the absence of SENP1/SENP2, the SUMOylation of the scaffolding 
Nup133 may block its interaction with other components of the scaffolding/peripheral 
core, therefore interfering with the assembly of this structure and, in turn, delocalization 
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of NPC components in the cytoplasm. Nup133 has been recently characterized to mediate 
NPC assembly through its curvature sensing domain (Doucet et al., 2010). It is proposed 
that the transmembrane nup Pom121 first establishes the NPC assembly site by inducing 
the fusion of INM/ONM. The induced membrane curvature is then thought to be detected 
by the sensing domain of Nup133, which subsequently targets itself and the binding 
components of the scaffolding core to the NPC assembly site (Doucet et al., 2010). 
SUMOylation may be involved in regulating the membrane curvature sensing mechanism 
of Nup133.  
Before any of these possibilities can be tested, the SUMOylation site(s) of 
Nup133 needs to be mapped. This can be done by first mutating individual lysines from 
the four predicted SUMO consensus sites. If SUMOylation occurs at a nonconsensus site, 
one could map the SUMO modification to individual domain(s) of Nup133 and narrow in 
for the candidate lysine. To determine whether Nup133 SUMOylation interferes with its 
interaction with other nucleoporins, GST fusion proteins of SUMOylated Nup133 can be 
purified using the bacterial SUMOylation system (Chapter 2) and test for interaction with 
candidate scaffolding binding partners of Nup133 such as Nup107, Nup43, Nup37, Sec13, 
and Seh1 (Loïodice et al., 2004; Belgareh et al., 2001). To determine whether Nup133 
SUMOylation could modulate its membrane curvature sensing, one could monitor the de 
novo NPC biogenesis of nonSUMOylatable mutant of Nup133 through 
immunofluorescence analysis in Hela cells. If mutating its SUMOylation site does not 
perturb its incorporation into nuclear envelope, this would indicate that SUMOylation of 
Nup133 may not be required for NPC biogenesis. In contrast, SUMOylation may 
interfere with its curvature sensing function. Since SUMOylation of Nup133 is not a 
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robust event and it is technically challenging to introduce SUMOylated Nup133 
recombinant fusion protein into tissue culture cells to examine its NPC incorporation, this 
hypothesis will have to be tested in an in vitro NPC assembly assay using Xenopus egg 
extract similarly employed by D’Angelo et al. In this assay, GFP-fusion protein of 
SUMOylated Nup133 would be purified using the bacterial SUMOylation strategy as 
described in Chapter 2. In the egg extract system, de novo NPC assembly can be studied 
in isolation by forming nuclei in the presence of the calcium chelator BAPTA which 
blocks the assembly of NPC. As BAPTA is diluted with untreated egg extract, NPC 
assembly/incorporation will be initiated (Macaulay and Forbes, 1996). If this is done in 
the presence of fluorescent SUMOylated Nup133 fusion protein, the incorporation of 
SUMOylated Nup133 into de novo NPC can be monitored following BAPTA removal. If 
Nup133 SUMOylation blocks its curvature sensing function, the SUMOylated GFP-
Nup133 recombinant protein would be defective in incorporation at the nuclear rim in 
this assay. 
Similar to Nup133, the SUMOylation of the nuclear basket component Nup153 
may interfere with its interaction with components of the scaffolding/peripheral core, 
thereby blocking the recruitment of these components to the NPC assembly site. An 
unexpected role of Nup153 in mediating the recruitment of scaffolding/peripheral core 
has been identified in this study in that Nup153 depletion blocks proper incorporation of 
Nup133 and Nup62 into NPCs. In this study, the function of Nup153 SUMOylation has 
been examined in the context of its interaction with another nuclear basket component, 
TPR. However, how Nup153 SUMOylation modulates its interaction with components of 
the scaffolding/peripheral core nups has not been tested. A similar strategy of purifying 
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SUMOylated Nup153 as described in Chapter 3 could be employed to more globally 
determine how SUMOylation of Nup153 impacts its network of interactions.  
4.5 The nuclear basket may regulate assembly of core 
scaffolding/peripheral nups 
 
Since the core scaffolding/peripheral nups are known to be critical for NPC 
biogenesis, the assembly defect of cytoplasmic fibril components upon the disruption of 
core scaffolding/peripheral nups may reflect a lack of core “seeding” sites for the 
assembly of cytoplasmic fibril components. While a postulated role of SENP1/SENP2 in 
regulating the scaffolding Nup133 or Nup205 awaits further verification, it is still unclear 
how the regulatory activities of SENP1/SENP2 are directed to the assembling scaffolding 
nups. Since nuclear basket intermediates can be assembled in the absence of full 
scaffolding/peripheral assemblies, it is possible that nuclear basket may serve as a 
platform to present SENP1/SENP2 activities to the assembling scaffolding nups. This 
possibility is supported by the finding that the nuclear basket component, Nup153 can 
interact with SENP1/SENP2, which suggests that a partnership of Nup153-
SENP1/SENP2 at the nuclear basket may impose regulation on the assembling 
scaffolding/peripheral core components. This model predicts that disruption of the 
Nup153-SENP1/SENP2 partnership would similarly lead to a NPC biogenesis defect. 
Indeed, depletion of Nup153 alone can lead to profound assembly defect of the 
scaffolding Nup133, the core peripheral Nup62, and components of the cytoplasmic fibril. 
Nup153 has been previously found to associate with Nup160, a component of the 
Nup107 complex with Nup133 as its constituent. In addition, Nup153 is also known to 
interact with numerous core transmembrane/scaffolding/peripheral nups including 
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Pom121, Nup160, Nup155, and Nup98 that reside in close proximity to Nup133. These 
interaction networks may allow Nup153 to present the regulatory activities of 
SENP1/SENP2 to Nup133 during NPC biogenesis.  
4.6 The N- and C-terminal domains of Nup153 may confer domain-specific 
targeting of SENP1/SENP2 substrates 
 
In this study, Nup153 is found to interact with SENP1/SENP2 through both its N- 
and C-terminal domains. Nup153 C-terminal domain is likely to have an importin-
mediated interaction with SENP1/SENP2; however, the SUMOylation of lysine 353 at 
Nup153 N-terminal domain provides a reinforcing recruitment signal for SENP1/SENP2. 
Such bimodal interactions of SENP1/SENP2 with Nup153 may confer unique regulation 
of SENP1/SENP2 activity. One possible model is that SENP1/SENP2 binding to 
different Nup153 domains allows the targeting SENP1/SENP2 activities towards specific 
subset of proteins that differentially bind to different domains of Nup153. Both N- and C-
terminal domains of Nup153 are binding platforms for a variety of macromolecules. 
Regulated targeting of SENP1/SENP2 to these binding domains may allow regulated 
deSUMOylation activities towards proteins that bind to these Nup153 domains. Mapping 
of Nup153’s domains required for NPC biogenesis may lead to new insights into how the 
different SENP-binding platforms of Nup153 regulate specific deSUMOylation targets. 
Mackay et al. have previously employed a panel of Nup153 truncation mutants targeting 
its N- and C-terminal domains to map functional domains of Nup153 in mediating its role 
in mitotic progression (Mackay et al., 2009). A similar domain mapping strategy would 
be useful in identifying the minimal functional domain of Nup153 required to coordinate 
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NPC biogenesis to fully decipher the involvement of SENP binding to individual 
domains.  
4.7 Ending remarks 
 
 This study has made new discovery about the function of NPC-associated SUMO 
proteases, with an exciting new model of NPC biogenesis involving the deSUMOylation 
activity of SENP1/SENP2. This model predicts that SUMO modification of nucleoporins, 
especially the central scaffolding/peripheral nups, could be a key event in imposing 
spatiotemporal regulation on nucleoporin assembly. In addition, components of the 
nuclear basket may establish an regulatory platform at NPC assembly site to coordinate 
the activity of the SENPs. Elucidating these possibilities may lead to more new insights 
of NPC biogenesis.  
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